| 1-AGPAT2 (1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)) | 1082 |
| 3-alpha-HSD (aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)) | 1098 |
| 5DII (deiodinase, iodothyronine, type II) | 1990 |
| 5-HT1A (5-hydroxytryptamine (serotonin) receptor 1A) | 2157 |
| 5-HT1B (5-hydroxytryptamine (serotonin) receptor 1B) | 2159 |
| 5-HT1D (5-hydroxytryptamine (serotonin) receptor 1D) | 2161 |
| 5-HT1DB (5-hydroxytryptamine (serotonin) receptor 1B) | 2159 |
| 5-HT2A (5-hydroxytryptamine (serotonin) receptor 2A) | 2161 |
| 5-HT2C (5-hydroxytryptamine (serotonin) receptor 2C) | 2164 |
| 5-HT-3 (5-hydroxytryptamine (serotonin) receptor 3A) | 2165 |
| 5-HT3A (5-hydroxytryptamine (serotonin) receptor 3A) | 2165 |
| 5-HT3R (5-hydroxytryptamine (serotonin) receptor 3A) | 2165 |
| 5HT3R (5-hydroxytryptamine (serotonin) receptor 3A) | 2165 |
| 5-HT3B (5-hydroxytryptamine (serotonin) receptor 3B) | 2168 |
| 5-HT6 (5-hydroxytryptamine (serotonin) receptor 6) | 2169 |
| 5-HT6R (5-hydroxytryptamine (serotonin) receptor 6) | 2169 |
| 5-HTR2C (5-hydroxytryptamine (serotonin) receptor 2C) | 2164 |
| 5-HTT (solute carrier family 6 (neurotransmitter transporter, serotonin), member 4) | 2397 |
| 5HT1a (5-hydroxytryptamine (serotonin) receptor 1A) | 2157 |
| 5HTT (solute carrier family 6 (neurotransmitter transporter, serotonin), member 4) | 2397 |
| 5-HTTLPR (solute carrier family 6 (neurotransmitter transporter, serotonin), member 4) | 2397 |
| 5-LO (arachidonate 5-lipoxygenase) | 1108 |
| 5-LOX (arachidonate 5-lipoxygenase) | 1108 |
| 5LPG (arachidonate 5-lipoxygenase) | 1108 |
| A | |
| A2M (alpha-2-macroglobulin) | 811 |
| A2MG (alpha-2-macroglobulin) | 811 |
| AAA (amyloid beta (A4) precursor protein) | 1161 |
| AAC2 (N-acetyltransferase 2 (arylamine N-acetyltransferase)) | 2293 |
| AADC (dopa decarboxylase (aromatic L-amino acid decarboxylase)) | 1988 |
| AAT5 (transforming growth factor, beta receptor 1) | 2448 |
| ABC1 (ATP-binding cassette, sub-family A (ABC1), member 1) | 812 |
| ABC-1 (ATP-binding cassette, sub-family A (ABC1), member 1) | 812 |
| ABC8 (ATP-binding cassette, sub-family G (WHITE), member 1) | 985 |
| ABC15 (ATP-binding cassette, sub-family G (WHITE), member 2) | 996 |
| ABC16 (ATP-binding cassette, sub-family B (MDR/TAP), member 11) | 928 |
| ABC17 (transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)) | 2437 |
| ABC20 (ATP-binding cassette, sub-family B (MDR/TAP), member 1) | 824 |
| ABC29 (ATP-binding cassette, sub-family C (CFTR/MRP), member 1) | 930 |
| ABC30 (ATP-binding cassette, sub-family C (CFTR/MRP), member 2) | 944 |
| ABC31 (ATP-binding cassette, sub-family C (CFTR/MRP), member 3) | 963 |
| ABC34 (ATP-binding cassette, sub-family C (CFTR/MRP), member 6) | 971 |
| ABC35 (cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)) | 1245 |
| ABC36 (ATP-binding cassette, sub-family C (CFTR/MRP), member 8) | 979 |
| ABCA1 (ATP-binding cassette, sub-family A (ABC1), member 1) | 812 |
| ABCB1 (ATP-binding cassette, sub-family B (MDR/TAP), member 1) | 824 |
| ABCB2 (transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)) | 2437 |
| ABCB11 (ATP-binding cassette, sub-family B (MDR/TAP), member 11) | 928 |
| ABCC (ATP-binding cassette, sub-family C (CFTR/MRP), member 1) | 930 |
| ABCC1 (ATP-binding cassette, sub-family C (CFTR/MRP), member 1) | 930 |
| ABCC2 (ATP-binding cassette, sub-family C (CFTR/MRP), member 2) | 944 |
| ABCC3 (ATP-binding cassette, sub-family C (CFTR/MRP), member 3) | 963 |
| ABCC4 (ATP-binding cassette, sub-family C (CFTR/MRP), member 4) | 965 |
| ABCC6 (ATP-binding cassette, sub-family C (CFTR/MRP), member 6) | 971 |
| ABCC7 (cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)) | 1245 |
| ABCC8 (ATP-binding cassette, sub-family C (CFTR/MRP), member 8) | 979 |
| ABCG1 (ATP-binding cassette, sub-family G (WHITE), member 1) | 985 |
| ABCG2 (ATP-binding cassette, sub-family G (WHITE), member 2) | 996 |
| ABCP (ATP-binding cassette, sub-family G (WHITE), member 2) | 996 |
| ABETA (amyloid beta (A4) precursor protein) | 1161 |
| ABL (c-abl oncogene 1, non-receptor tyrosine kinase) | 1025 |
| ABL (microsomal triglyceride transfer protein) | 2291 |
| ABL1 (c-abl oncogene 1, non-receptor tyrosine kinase) | 1025 |
| ABPP (amyloid beta (A4) precursor protein) | 1161 |
| AC9 (adenylate cyclase 9) | 1049 |
| ACAC (acetyl-coA carboxylase alpha) | 1026 |
| ACACA (acetyl-coA carboxylase alpha) | 1026 |
| ACAT (carboxylesterase 1 (monocyte/macrophage serine esterase 1)) | 1241 |
| ACC (acetyl-coA carboxylase alpha) | 1026 |
| ACC1 (acetyl-coA carboxylase alpha) | 1026 |
| ACCA (acetyl-coA carboxylase alpha) | 1026 |
| ACDC (adiponectin, C1Q and collagen domain containing) | 1056 |
| ACE (angiotensin I converting enzyme (peptidyl-dipeptidase A) 1) | 1027 |
| ACE1 (angiotensin I converting enzyme (peptidyl-dipeptidase A) 1) | 1027 |
| ACE2 (angiotensin I converting enzyme (peptidyl-dipeptidase A) 2) | 1034 |
| ACEH (angiotensin I converting enzyme (peptidyl-dipeptidase A) 2) | 1034 |
| ACHE (acetylcholinesterase (Yt blood group)) | 1036 |
| ACHRA (cholinergic receptor, nicotinic, alpha 1 (muscle)) | 1252 |
| ACHRD (cholinergic receptor, nicotinic, alpha 1 (muscle)) | 1252 |
| ACOX (acyl-CoA oxidase 1, palmitoyl) | 1041 |
| ACOX1 (acyl-CoA oxidase 1, palmitoyl) | 1041 |
| ACRP30 (adiponectin, C1Q and collagen domain containing) | 1056 |
| ACS1 (acyl-CoA synthetase long-chain family member 1) | 1042 |
| ACS2 (acyl-CoA synthetase long-chain family member 5) | 1045 |
| ACS2 (acyl-CoA synthetase long-chain family member 6) | 1046 |
| ACS3 (acyl-CoA synthetase long-chain family member 3) | 1043 |
| ACS4 (acyl-CoA synthetase long-chain family member 4) | 1044 |
| ACS5 (acyl-CoA synthetase long-chain family member 5) | 1045 |
| ACSL1 (acyl-CoA synthetase long-chain family member 1) | 1042 |
| ACSL3 (acyl-CoA synthetase long-chain family member 3) | 1043 |
| ACSL4 (acyl-CoA synthetase long-chain family member 4) | 1044 |
| ACSL5 (acyl-CoA synthetase long-chain family member 5) | 1045 |
| ACSL6 (acyl-CoA synthetase long-chain family member 6) | 1046 |
| ACVRL1 (activin A receptor, type II-like 1) | 1046 |
| ACVRLK1 (activin A receptor, type II-like 1) | 1046 |
| ACVRLK4 (transforming growth factor, beta receptor 1) | 2448 |
| AD1 (amyloid beta (A4) precursor protein) | 1161 |
| AD2 (apolipoprotein E) | 1121 |
| AD3 (presenilin 1) | 2353 |
| AD3L (presenilin 2 (Alzheimer disease 4)) | 2357 |
| AD4 (presenilin 2 (Alzheimer disease 4)) | 2357 |
| ADA (adenosine deaminase) | 1047 |
| ADABP (dipeptidyl-peptidase 4) | 1992 |
| ADCP2 (dipeptidyl-peptidase 4) | 1992 |
| ADCP-2 (dipeptidyl-peptidase 4) | 1992 |
| ADCY9 (adenylate cyclase 9) | 1049 |
| ADD1 (adducin 1 (alpha)) | 1050 |
| ADDA (adducin 1 (alpha)) | 1050 |
| ADH (alcohol dehydrogenase 1A (class 1), alpha polypeptide) | 1052 |
| ADH1 (alcohol dehydrogenase 1A (class 1), alpha polypeptide) | 1052 |
| ADH1A (alcohol dehydrogenase 1A (class 1), alpha polypeptide) | 1052 |
| ADH1B (alcohol dehydrogenase 1B (class 1), beta polypeptide) | 1053 |
| ADH1C (alcohol dehydrogenase 1C (class 1), gamma polypeptide)) | 1054 |
| ADH2 (alcohol dehydrogenase 1B (class 1), beta polypeptide) | 1053 |
| ADH3 (alcohol dehydrogenase 1C (class 1), gamma polypeptide)) | 1054 |
| ADHD7 (tryptophan hydroxylase 2) | 2475 |
| ADIPOQ (adiponectin, C1Q and collagen domain containing) | 1056 |
| ADIPQTL1 (adiponectin, C1Q and collagen domain containing) | 1056 |
| ADORA2 (adenosine A2a receptor) | 1060 |
| ADORA2A (adenosine A2a receptor) | 1060 |
| ADPG-R (purinergic receptor P2Y, G-protein coupled, 12) | 2324 |
| ADPN (adiponectin, C1Q and collagen domain containing) | 1056 |
| ADRA1A (adrenergic, alpha-1A-, receptor) | 1062 |
| ADRA1C (adrenergic, alpha-1A-, receptor) | 1062 |
| ADRA1L1 (adrenergic, alpha-1A-, receptor) | 1062 |
| ADRA2 (adrenergic, alpha-2A-, receptor) | 1064 |
| ADRA2A (adrenergic, alpha-2A-, receptor) | 1064 |
| ADRA2C (adrenergic alpha-2C-receptor) | 1067 |
| ADRA2L2 (adrenergic alpha-2C-receptor) | 1067 |
| ADRA2R (adrenergic, alpha-2A-, receptor) | 1064 |
| ADRA2RL2 (adrenergic alpha-2C-receptor) | 1067 |
| ADRAR (adrenergic, alpha-2A-, receptor) | 1064 |
| ADRARL2 (adrenergic alpha-2C-receptor) | 1067 |
| ADRB1 (adrenergic, beta-1-, receptor) | 1069 |
| ADRB1R (adrenergic, beta-1-, receptor) | 1069 |
| ADRB2 (adrenergic, beta-2-, receptor, surface) | 1073 |
| ADRB2R (adrenergic, beta-2-, receptor, surface) | 1073 |
| ADRB2RL1 (5-hydroxytryptamine (serotonin) receptor 1A) | 2157 |
| ADRB3 (adrenergic, beta-3-, receptor) | 1080 |
| ADRBR (adrenergic, beta-2-, receptor, surface) | 1073 |
| ADRBRL1 (5-hydroxytryptamine (serotonin) receptor 1A) | 2157 |
| ADU (adducin 1 (alpha)) | 1050 |
| AF097490.1 (solute carrier family 22 (organic anion transporter), member 6) | 2408 |
| AG2S (angiotensin II receptor, type 1) | 1088 |
| AGP1 (orosomucoid 1) | 2323 |
| AGPA (orosomucoid 1) | 2323 |
| AGP-A (orosomucoid 1) | 2323 |
| AGPAT2 (1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)) | 1082 |
| AGT (angiotensinogen (serpin peptidase inhibitor, clade A, member 8)) | 1083 |
| AGT (alanine-glyoxylate aminotransferase) | 1092 |
| AGT1 (alanine-glyoxylate aminotransferase) | 1092 |
| AGTR1 (angiotensin II receptor, type 1) | 1088 |
| AGTR1A (angiotensin II receptor, type 1) | 1088 |
| AGTR1B (angiotensin II receptor, type 1) | 1088 |
| AGXT (alanine-glyoxylate aminotransferase) | 1092 |
| AGXT1 (alanine-glyoxylate aminotransferase) | 1092 |
| AHH (cytochrome P450, family 1, subfamily A, polypeptide 1) | 1275 |
| AHO (GNAS complex locus) | 2089 |
| AHR (aryl hydrocarbon receptor) | 1093 |
| AHRR (cytochrome P450, family 1, subfamily A, polypeptide 1) | 1275 |
| AHUS1 (complement factor H) | 1244 |
| AHUS6 (thrombomodulin) | 2449 |
| AICAR (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase) | 1191 |
| AICARFT (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase) | 1191 |
| AIG6 (FK506 binding protein 5) | 2061 |
| AIS (androgen receptor) | 1183 |
| AIT (solute carrier family 5 (iodide transporter), member 8) | 2393 |
| AKR1C4 (aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)) | 1098 |
| ALAD (aminolevulinate dehydratase) | 1099 |
| ALADH (aminolevulinate dehydratase) | 1099 |
| ALAP (endoplasmic reticulum aminopeptidase 1) | 2022 |
| A-LAP (endoplasmic reticulum aminopeptidase 1) | 2022 |
| ALDC (aldehyde dehydrogenase 1 family, member A1) | 1100 |
| ALDH1 (aldehyde dehydrogenase 1 family, member A1) | 1100 |
| ALDH1A1 (aldehyde dehydrogenase 1 family, member A1) | 1100 |
| ALDH2 (aldehyde dehydrogenase 2 family (mitochondrial)) | 1103 |
| ALDH3 (aldehyde dehydrogenase 3 family, member A1) | 1106 |
| ALDH3A1 (aldehyde dehydrogenase 3 family, member A1) | 1106 |
| ALDH11 (aldehyde dehydrogenase 1 family, member A1) | 1100 |
| ALDH-E1 (aldehyde dehydrogenase 1 family, member A1) | 1100 |
| ALDH-E2 (aldehyde dehydrogenase 2 family (mitochondrial)) | 1103 |
| ALDHI (aldehyde dehydrogenase 2 family (mitochondrial)) | 1103 |
| ALDHIII (aldehyde dehydrogenase 3 family, member A1) | 1106 |
| ALDM (aldehyde dehydrogenase 2 family (mitochondrial)) | 1103 |
| ALDOS (cytochrome P450, family 11, subfamily B, polypeptide 2) | 1932 |
| ALK1 (activin A receptor, type II-like 1) | 1046 |
| ALK-1 (activin A receptor, type II-like 1) | 1046 |
| ALK5 (transforming growth factor, beta receptor 1) | 2448 |
| ALK-5 (transforming growth factor, beta receptor 1) | 2448 |
| ALL (breakpoint cluster region) | 1196 |
| ALOX5 (arachidonate 5-lipoxygenase) | 1108 |
| ALPHA1AAR (adrenergic, alpha-1A-, receptor) | 1062 |
| ALPHA2AAR (adrenergic, alpha-2A-, receptor) | 1064 |
| ALPHA2CAR (adrenergic alpha-2C-receptor) | 1067 |
| AMBP1 (complement factor H) | 1244 |
| ANF (natriuretic peptide precursor A) | 2304 |
| ANHU (angiotensinogen (serpin peptidase inhibitor, clade A, member 8)) | 1083 |
| ANP (natriuretic peptide precursor A) | 2304 |
| AO (aldehyde oxidase 1) | 1111 |
| AOE37-2 (peroxiredoxin 4) | 2347 |
| AOH1 (aldehyde oxidase 1) | 1111 |
| AOX1 (aldehyde oxidase 1) | 1111 |
| AP-1 (FBJ murine osteosarcoma viral oncogene homolog) | 2070 |
| APC (protein C (inactivator of coagulation factors Va and VIIIa)) | 2352 |
| APM1 (adiponectin, C1Q and collagen domain containing) | 1056 |
| APM-1 (adiponectin, C1Q and collagen domain containing) | 1056 |
| APOA1 (apolipoprotein A-I) | 1115 |
| APOA5 (apolipoprotein A-V) | 1116 |
| APOAV (apolipoprotein A-V) | 1116 |
| APOA-V (apolipoprotein A-V) | 1116 |
| APOB (apolipoprotein B (including Ag(x) antigen)) | 1118 |
| APOC3 (apolipoprotein C-III) | 1119 |
| APOCIII (apolipoprotein C-III) | 1119 |
| APOD (apolipoprotein D) | 1120 |
| APOE (apolipoprotein E) | 1121 |
| Apo-E (apolipoprotein E) | 1121 |
| APP (amyloid beta (A4) precursor protein) | 1161 |
| APPI (amyloid beta (A4) precursor protein) | 1161 |
| APPILS (endoplasmic reticulum aminopeptidase 1) | 2022 |
| APRF (signal transducer and activator of transcription 3 (acute-phase response factor)) | 2428 |
| APT1 (transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)) | 2437 |
| AR (androgen receptor) | 1183 |
| ARA (ATP-binding cassette, sub-family C (CFTR/MRP), member 6) | 971 |
| ARACHE (acetylcholinesterase (Yt blood group) | 1036 |
| ARF (cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4)) | 1238 |
| ARG1 (arginase, liver) | 1189 |
| AR-JP (parkinson protein 2, E3 ubiquitin protein ligase (parkin)) | 2325 |
| ARLK1 (activin A receptor, type II-like 1) | 1046 |
| ARMD4 (complement factor H) | 1244 |
| ARMD5 (excision repair cross-complementing rodent repair deficiency, complementation group 6) | 2032 |
| ARMD10 (toll-like receptor 4) | 2451 |
| ARMS1 (complement factor H) | 1244 |
| ARO (cytochrome P450, family 19, subfamily A, polypeptide 1) | 1943 |
| ARO1 (cytochrome P450, family 19, subfamily A, polypeptide 1) | 1943 |
| ARTS1 (endoplasmic reticulum aminopeptidase 1) | 2022 |
| ARTS-1 (endoplasmic reticulum aminopeptidase 1) | 2022 |
| ARY2 (N-acetyltransferase 2 (arylamine N-acetyltransferase)) | 2293 |
| AS (major histocompatibility complex, class I, B) | 2131 |
| AS3MT (arsenic (+3 oxidation state) methyltransferase) | 1190 |
| ASBT (solute carrier family 10 (sodium/bile acid cotransporter family), member 2) | 2400 |
| ASCR (prion protein) | 2347 |
| AsMT (arsenic (+3 oxidation state) methyltransferase) | 1190 |
| AT1 (angiotensin II receptor, type 1) | 1088 |
| AT1B (angiotensin II receptor, type 1) | 1088 |
| AT1R (angiotensin II receptor, type 1) | 1088 |
| AT2R1 (angiotensin II receptor, type 1) | 1088 |
| AT2R1A (angiotensin II receptor, type 1) | 1088 |
| AT2R1B (angiotensin II receptor, type 1) | 1088 |
| ATFB1 (potassium voltage-gated channel, KQT-like subfamily, member 1) | 2234 |
| ATFB3 (potassium voltage-gated channel, KQT-like subfamily, member 1) | 2234 |
| ATFB4 (potassium voltage-gated channel, Isk-related family, member 2) | 2229 |
| ATFB6 (natriuretic peptide precursor A) | 2304 |
| ATIC (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase) | 1191 |
| ATP6 (mitochondrially encoded ATP synthase 6) | 2279 |
| ATP7A (ATPase, Cu++ transporting, alpha polypeptide) | 1192 |
| ATPase6 (mitochondrially encoded ATP synthase 6) | 2279 |
| AURA17 (leucine-rich repeat kinase 2) | 2253 |
| AUTS9 (met proto-oncogene (hepatocyte growth factor receptor) | 2269 |
| AWP1 (zinc finger, AN1-type, domain 6) | 2529 |
| AY046562.1 (5,10-methylenetetrahydrofolate reductase (NADPH)) | 2285 |
| B | |
| B1AR (adrenergic, beta-1-, receptor) | 1069 |
| B2AR (adrenergic, beta-2-, receptor, surface) | 1073 |
| B2R (bradykinin receptor B2) | 1197 |
| B15 (NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 4, 15kDa) | 2296 |
| bA127L20.1 (glutathione S-transferase omega 2) | 2113 |
| bA416N4.2 (synaptosomal-associated protein, 25kDa) | 2418 |
| BAR (adrenergic, beta-2-, receptor, surface) | 1073 |
| BAR2 (adrenergic, beta-2-, receptor, surface) | 1073 |
| BB2 (intercellular adhesion molecule 1) | 2175 |
| BCA1 (breast cancer antiestrogen resistance 1) | 1194 |
| BCAR1 (breast cancer antiestrogen resistance 1) | 1194 |
| BCGF-1 (interleukin 4) | 2201 |
| BCHE (butyrylcholinesterase) | 1194 |
| BCL1 (cyclin D1) | 1220 |
| BCR (breakpoint cluster region) | 1196 |
| BCR1 (breakpoint cluster region) | 1196 |
| bcr/abl (c-abl oncogene 1, non-receptor tyrosine kinase) | 1025 |
| BCRP (ATP-binding cassette, sub-family G (WHITE), member 2) | 996 |
| BCRP1 (ATP-binding cassette, sub-family G (WHITE), member 2) | 996 |
| BDKRB2 (bradykinin receptor B2) | 1197 |
| BDNF (brain-derived neurotrophic factor) | 1198 |
| BETA1AR (adrenergic, beta-1-, receptor) | 1069 |
| BETA2AR (adrenergic, beta-2-, receptor, surface) | 1073 |
| BETA3AR (adrenergic, beta-3-, receptor) | 1080 |
| BFIC3 (sodium channel, voltage-gated, type II, alpha subunit) | 2386 |
| BH (bleomycin hydrolase) | 1201 |
| bHLHb12 (upstream transcription factor 2, c-fos interacting) | 2510 |
| bHLHe76 (aryl hydrocarbon receptor) | 1093 |
| BILIQTL1 (UDP glucuronosyltransferase 1 family, polypeptide A1) | 2483 |
| BIR (potassium inwardly-rectifying channel, subfamily J, member 11) | 2232 |
| BK2 (bradykinin receptor B2) | 1197 |
| BK-2 (bradykinin receptor B2) | 1197 |
| BKR2 (bradykinin receptor B2) | 1197 |
| BLK (B lymphoid tyrosine kinase) | 1200 |
| BLMH (bleomycin hydrolase) | 1201 |
| BMDP (ATP-binding cassette, sub-family G (WHITE), member 2) | 996 |
| BMH (bleomycin hydrolase) | 1201 |
| BMIQ4 (uncoupling protein 2 (mitochondrial, proton carrier)) | 2482 |
| BMK1 (mitogen-activated protein kinase 7) | 2261 |
| BMPR2 (bone morphogenetic protein receptor, type II (serine/threonine kinase)) | 1202 |
| BMPR3 (bone morphogenetic protein receptor, type II (serine/threonine kinase)) | 1202 |
| BMPR-II (bone morphogenetic protein receptor, type II (serine/threonine kinase)) | 1202 |
| BMR2 (bone morphogenetic protein receptor, type II (serine/threonine kinase)) | 1202 |
| BP (haptoglobin) | 2152 |
| BR (integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)) | 2224 |
| BRAF (v-raf murine sarcoma viral oncogene homolog B1) | 1203 |
| BRAF1 (v-raf murine sarcoma viral oncogene homolog B1) | 1203 |
| B-RAF1 (v-raf murine sarcoma viral oncogene homolog B1) | 1203 |
| BRB2 (bradykinin receptor B2) | 1197 |
| BRC2 (breast cancer 2, early onset) | 1208 |
| BRCA1 (breast cancer 1, early onset) | 1204 |
| BRCA2 (breast cancer 2, early onset) | 1208 |
| BRCAI (breast cancer 1, early onset) | 1204 |
| BRCC1 (breast cancer 1, early onset) | 1204 |
| BRCC2 (breast cancer 2, early onset) | 1208 |
| BRIC2 (ATP-binding cassette, sub-family B (MDR/TAP), member 11) | 928 |
| BRK3 (bone morphogenetic protein receptor, type II (serine/threonine kinase)) | 1202 |
| BRK-3 (bone morphogenetic protein receptor, type II (serine/threonine kinase)) | 1202 |
| BROVCA1 (breast cancer 1, early onset) | 1204 |
| BROVCA2 (breast cancer 2, early onset) | 1208 |
| BSCL (1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)) | 1082 |
| BSCL1 (1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)) | 1082 |
| BSEP (ATP-binding cassette, sub-family B (MDR/TAP), member 11) | 928 |
| BSF1 (interleukin 4) | 2201 |
| BSF2 (interleukin 6 (interferon, beta 2)) | 2204 |
| BTPS2 (adenomatous polyposis coli) | 1112 |
| BXR (nuclear receptor subfamily 1, group I, member 2) | 2309 |
| C | |
| C6ST (carbohydrate (chondroitin 6) sulfotransferase 3) | 1256 |
| C6ST1 (carbohydrate (chondroitin 6) sulfotransferase 3) | 1256 |
| C11 (aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)) | 1098 |
| C20orf37 (inosine triphosphatase (nucleoside triphosphate pyrophosphatase)) | 2227 |
| C20orf45 (GNAS complex locus) | 2089 |
| c-ABL (c-abl oncogene 1, non-receptor tyrosine kinase) | 1025 |
| CACHECTIN (tumor necrosis factor (TNF superfamily, member 2) | 2453 |
| CACNG2 (calcium channel, voltage-dependent, gamma subunit 2) | 1210 |
| CADASIL (notch 3) | 2301 |
| CALU (calumenin) | 1210 |
| CANN6 (cannabinoid receptor 1 (brain)) | 1257 |
| CAR (calcium-sensing receptor) | 1211 |
| CAR (spastic paraplegia 7 (pure and complicated autosomal recessive)) | 2425 |
| CAR1 (nuclear receptor subfamily 1, group I, member 3) | 2313 |
| CAR-BETA (nuclear receptor subfamily 1, group I, member 3) | 2313 |
| CAR-SV1 (nuclear receptor subfamily 1, group I, member 3) | 2313 |
| CAR-SV4 (nuclear receptor subfamily 1, group I, member 3) | 2313 |
| CAR-SV6 (nuclear receptor subfamily 1, group I, member 3) | 2313 |
| CAR-SV7 (nuclear receptor subfamily 1, group I, member 3) | 2313 |
| CAR-SV8 (nuclear receptor subfamily 1, group I, member 3) | 2313 |
| CAR-SV9 (nuclear receptor subfamily 1, group I, member 3) | 2313 |
| CAR-SV10 (nuclear receptor subfamily 1, group I, member 3) | 2313 |
| CAR-SV11 (nuclear receptor subfamily 1, group I, member 3) | 2313 |
| CAR-SV12 (nuclear receptor subfamily 1, group I, member 3) | 2313 |
| CAR-SV13 (nuclear receptor subfamily 1, group I, member 3) | 2313 |
| CAR-SV14 (nuclear receptor subfamily 1, group I, member 3) | 2313 |
| CAR-SV15 (nuclear receptor subfamily 1, group I, member 3) | 2313 |
| CAR-SV17 (nuclear receptor subfamily 1, group I, member 3) | 2313 |
| CAR-SV18 (nuclear receptor subfamily 1, group I, member 3) | 2313 |
| CAR-SV19 (nuclear receptor subfamily 1, group I, member 3) | 2313 |
| CAR-SV20 (nuclear receptor subfamily 1, group I, member 3) | 2313 |
| CAR-SV21 (nuclear receptor subfamily 1, group I, member 3) | 2313 |
| CAS (breast cancer antiestrogen resistance 1) | 1194 |
| CAS1 (breast cancer antiestrogen resistance 1) | 1194 |
| CASIL (notch 3) | 2301 |
| CASR (calcium-sensing receptor) | 1211 |
| CASS1 (breast cancer antiestrogen resistance 1) | 1194 |
| CAT (catalase) | 1212 |
| CB1 (cannabinoid receptor 1 (brain)) | 1257 |
| CB1A (cannabinoid receptor 1 (brain)) | 1257 |
| CB1K5 (cannabinoid receptor 1 (brain)) | 1257 |
| CB1R (cannabinoid receptor 1 (brain)) | 1257 |
| CBAVD (cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)) | 1245 |
| cblG (5-methyltetrahydrofolate-homocysteine methyltransferase) | 2290 |
| CB-R (cannabinoid receptor 1 (brain)) | 1257 |
| CBR (carbonyl reductase 1) | 1217 |
| CBR1 (carbonyl reductase 1) | 1217 |
| CBR3 (carbonyl reductase 3) | 1218 |
| CBS (cystathionine beta-synthase) | 1219 |
| C-C (interleukin 8 receptor, alpha) | 2211 |
| C-C-CKR-1 (interleukin 8 receptor, alpha) | 2211 |
| CC-CKR-5 (chemokine (C-C motif) receptor 5) | 1223 |
| CCCKR5 (chemokine (C-C motif) receptor 5) | 1223 |
| CCND1 (cyclin D1) | 1220 |
| CCO (ryanodine receptor 1 (skeletal)) | 2382 |
| CCR5 (chemokine (C-C motif) receptor 5) | 1223 |
| CD (cytotoxic T-lymphocyte-associated protein 4) | 1273 |
| CD (major histocompatibility complex, class II, DQ alpha 1) | 2139 |
| CD16 (Fc fragment of IgG, low affinity IIIa, receptor (CD16a)) | 2057 |
| CD16A (Fc fragment of IgG, low affinity IIIa, receptor (CD16a)) | 2057 |
| CD16a (Fc fragment of IgG, low affinity IIIa, receptor (CD16a)) | 2057 |
| CD23 (Fc fragment of IgE, low affinity II, receptor for (CD23)) | 2054 |
| CD26 (dipeptidyl-peptidase 4) | 1992 |
| CD32 (Fc fragment of IgG, low affinity IIa, receptor (CD32)) | 2055 |
| CD32A (Fc fragment of IgG, low affinity IIa, receptor (CD32)) | 2055 |
| CD36L1 (scavenger receptor class B, member 1) | 2384 |
| CD49B (integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)) | 2224 |
| CD54 (intercellular adhesion molecule 1) | 2175 |
| CD61 (integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)) | 2225 |
| CD106 (vascular cell adhesion molecule 1) | 2512 |
| CD113t-C (hemoglobin, beta) | 2122 |
| CD115 (colony stimulating factor 1 receptor) | 1270 |
| CD117 (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog) | 2237 |
| CD120a (tumor necrosis factor receptor superfamily, member 1A) | 2464 |
| CD120b (tumor necrosis factor receptor subfamily, member 1B) | 2465 |
| CD126 (interleukin 6 receptor) | 2210 |
| CD128 (interleukin 8 receptor, alpha) | 2211 |
| CD135 (fms-related tyrosine kinase 3) | 2062 |
| CD140A (platelet-derived growth factor receptor, alpha polypeptide) | 2328 |
| CD140B (platelet-derived growth factor receptor, beta polypeptide) | 2330 |
| CD141 (thrombomodulin) | 2449 |
| CD143 (angiotensin I converting enzyme (peptidyl-dipeptidase A) 1) | 1027 |
| CD152 (cytotoxic T-lymphocyte-associated protein 4) | 1273 |
| CD181 (interleukin 8 receptor, alpha) | 2211 |
| CD182 (interleukin 8 receptor, beta) | 2212 |
| CD195 (chemokine (C-C motif) receptor 5) | 1223 |
| CD230 (prion protein) | 2347 |
| CD243 (ATP-binding cassette, sub-family B (MDR/TAP), member 1) | 824 |
| CD284 (toll-like receptor 4) | 2451 |
| CD295 (leptin receptor) | 2248 |
| CD309 (kinase insert domain receptor (a type III receptor tyrosine kinase)) | 2236 |
| CD338 (ATP-binding cassette, sub-family G (WHITE), member 2) | 996 |
| CD340 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)) | 2023 |
| CDA (cytidine deaminase) | 1229 |
| CDABP0067 (major histocompatibility complex, class I, B) | 2131 |
| CDC2 (cyclin-dependent kinase 1) | 1229 |
| CDC28A (cyclin-dependent kinase 1) | 1229 |
| CDCD2 (sodium channel, voltage-gated, type V, alpha subunit) | 2388 |
| CDD (cytidine deaminase) | 1229 |
| CDD-ANF (natriuretic peptide precursor A) | 2304 |
| CDHF12 (ret proto-oncogene) | 2377 |
| CDHR16 (ret proto-oncogene) | 2377 |
| CDK1 (cyclin-dependent kinase 1) | 1229 |
| CDK2 (cyclin-dependent kinase 2) | 1232 |
| CDK4 (cyclin-dependent kinase 4) | 1234 |
| CDK4I (cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4)) | 1238 |
| CDK6 (cyclin-dependent kinase 6) | 1236 |
| CDKN2 (cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4)) | 1238 |
| CDKN2A (cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4)) | 1238 |
| CDR (aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)) | 1098 |
| CDw32 (Fc fragment of IgG, low affinity IIa, receptor (CD32)) | 2055 |
| CDw128a (interleukin 8 receptor, alpha) | 2211 |
| CDw128b (interleukin 8 receptor, beta) | 2212 |
| CDw338 (ATP-binding cassette, sub-family G (WHITE), member 2) | 996 |
| CE-2 (carboxylesterase 2 (intestine, liver)) | 1242 |
| CED (transforming growth factor, beta 1) | 2442 |
| CEH (carboxylesterase 1 (monocyte/macrophage serine esterase 1)) | 1241 |
| CELIAC1 (major histocompatibility complex, class II, DQ alpha 1) | 2139 |
| CELIAC3 (cytotoxic T-lymphocyte-associated protein 4) | 1273 |
| CERP (ATP-binding cassette, sub-family A (ABC1), member 1) | 812 |
| CES1 (carboxylesterase 1 (monocyte/macrophage serine esterase 1)) | 1241 |
| CES1A1 (carboxylesterase 1 (monocyte/macrophage serine esterase 1)) | 1241 |
| CES1A2 (carboxylesterase 1 (monocyte/macrophage serine esterase 1)) | 1241 |
| CES2 (carboxylesterase 2 (intestine, liver)) | 1242 |
| CES2A1 (carboxylesterase 2 (intestine, liver)) | 1242 |
| CETP (cholesteryl ester transfer protein, plasma) | 1243 |
| CF (cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)) | 1245 |
| CFH (complement factor H) | 1244 |
| CFHL3 (complement factor H) | 1244 |
| C-FMS (colony stimulating factor 1 receptor) | 1270 |
| C-FOS (FBJ murine osteosarcoma viral oncogene homolog) | 2070 |
| CFTR (cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)) | 1245 |
| CFTR/MRP (cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)) | 1245 |
| CGB-PDE (phosphodiesterase 5A, cGMP-specific) | 2327 |
| CHAT (choline O-acetyltransferase) | 1248 |
| CHDH (choline dehydrogenase) | 1249 |
| CHDR (aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)) | 1098 |
| CHDS6 (matrix metalloproteinase 3 (stromelysin 1, progelatinase)) | 2276 |
| CHE1 (butyrylcholinesterase) | 1194 |
| ChlorRed (aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)) | 1098 |
| CHMD (solute carrier family 19 (folate transporter), member 1) | 2404 |
| CHOACTASE (choline O-acetyltransferase) | 1248 |
| CHRM1 (cholinergic receptor, muscarinic 1) | 1249 |
| CHRM2 (cholinergic receptor, muscarinic 2) | 1250 |
| CHRM3 (cholinergic receptor, muscarinic 3) | 1251 |
| CHRNA (cholinergic receptor, nicotinic, alpha 1 (muscle)) | 1252 |
| CHRNA1 (cholinergic receptor, nicotinic, alpha 1 (muscle)) | 1252 |
| CHRNA4 (cholinergic receptor, nicotinic, alpha 4) | 1253 |
| CHRNA5 (cholinergic receptor, nicotinic, alpha 5) | 1254 |
| CHRNB2 (cholinergic receptor, nicotinic, beta 2 (neuronal)) | 1255 |
| CHST3 (carbohydrate (chondroitin 6) sulfotransferase 3) | 1256 |
| CI-B15 (NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 4, 15kDa) | 2296 |
| CIKM5 (Fc fragment of IgG, low affinity IIa, receptor (CD32)) | 2055 |
| CIMT1 (peroxisome proliferator-activated receptor gamma) | 2342 |
| CJD (prion protein) | 2347 |
| C-Kit (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog) | 2237 |
| CKN2 (excision repair cross-complementing rodent repair deficiency, complementation group 6) | 2032 |
| CKR-1 (interleukin 8 receptor, alpha) | 2211 |
| CKR5 (chemokine (C-C motif) receptor 5) | 1223 |
| CKR-5 (chemokine (C-C motif) receptor 5) | 1223 |
| C-K-RAS (v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) | 2239 |
| CLA1 (scavenger receptor class B, member 1) | 2384 |
| CLA-1 (scavenger receptor class B, member 1) | 2384 |
| CLCS (ATP-binding cassette, sub-family B (MDR/TAP), member 1) | 824 |
| CLEC4J (Fc fragment of IgE, low affinity II, receptor for (CD23)) | 2054 |
| CLG4 (matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)) | 2274 |
| CLG4A (matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)) | 2274 |
| CLMF (interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40)) | 2218 |
| CLMF2 (interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40)) | 2218 |
| CMAR (spastic paraplegia 7 (pure and complicated autosomal recessive)) | 2425 |
| CMD1E (sodium channel, voltage-gated, type V, alpha subunit) | 2388 |
| CMD1V (presenilin 2 (Alzheimer disease 4)) | 2357 |
| c-Met (met proto-oncogene (hepatocyte growth factor receptor) | 2269 |
| CMKAR1 (interleukin 8 receptor, alpha) | 2211 |
| CMKAR2 (interleukin 8 receptor, beta) | 2212 |
| CMKBR5 (chemokine (C-C motif) receptor 5) | 1223 |
| CML (breakpoint cluster region) | 1196 |
| CMM2 (cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4)) | 1238 |
| CMM3 (cyclin-dependent kinase 4) | 1234 |
| CMM5 (melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)) | 2266 |
| CMOAT (ATP-binding cassette, sub-family C (CFTR/MRP), member 2) | 944 |
| cMOAT2 (ATP-binding cassette, sub-family C (CFTR/MRP), member 3) | 963 |
| CMPD2 (sodium channel, voltage-gated, type V, alpha subunit) | 2388 |
| cMRP (ATP-binding cassette, sub-family C (CFTR/MRP), member 2) | 944 |
| CMS1A (choline O-acetyltransferase) | 1248 |
| CMS1A2 (choline O-acetyltransferase) | 1248 |
| CMS2A (cholinergic receptor, nicotinic, alpha 1 (muscle)) | 1252 |
| CN5A (phosphodiesterase 5A, cGMP-specific) | 2327 |
| CNR (cannabinoid receptor 1 (brain)) | 1257 |
| CNR1 (cannabinoid receptor 1 (brain)) | 1257 |
| CNT1 (solute carrier family 28 (sodium-coupled nucleoside transporter), member 1) | 2412 |
| CNT2 (solute carrier family 28 (sodium-coupled nucleoside transporter), member 2) | 2413 |
| COCA1 (mutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli)) | 2278 |
| COCA2 (mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli)) | 2272 |
| COFS (excision repair cross-complementing rodent repair deficiency, complementation group 6) | 2032 |
| COFS1 (excision repair cross-complementing rodent repair deficiency, complementation group 6) | 2032 |
| COFS2 (excision repair cross-complementing rodent repair deficiency, complementation group 2) | 2029 |
| COFS4 (excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)) | 2028 |
| COI (mitochondrially encoded cytochrome c oxidase I) | 2280 |
| COL1A1 (collagen, type I, alpha 1) | 1259 |
| COMT (catechol-O-methyltransferase) | 1262 |
| COX1 (mitochondrially encoded cytochrome c oxidase I) | 2280 |
| COX1 (prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)) | 2365 |
| COX2 (prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)) | 2367 |
| COX-2 (prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)) | 2367 |
| COX3 (prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)) | 2365 |
| CP1B (cytochrome P450, family 1, subfamily B, polypeptide 1) | 1335 |
| CP7A (cytochrome P450, family 7, subfamily A, polypeptide 1) | 1911 |
| CP11 (cytochrome P450, family 1, subfamily A, polypeptide 1) | 1275 |
| CP12 (cytochrome P450, family 1, subfamily A, polypeptide 2) | 1297 |
| CP27 (cytochrome P450, family 27, subfamily A, polypeptide 1) | 1979 |
| CP33 (cytochrome P450, family 3, subfamily A, polypeptide 4) | 1622 |
| CP34 (cytochrome P450, family 3, subfamily A, polypeptide 4) | 1622 |
| CP35 (cytochrome P450, family 3, subfamily A, polypeptide 5) | 1901 |
| CPA6 (cytochrome P450, family 2, subfamily A, polypeptide 6) | 1347 |
| CPAMD5 (alpha-2-macroglobulin) | 811 |
| CPB6 (cytochrome P450, family 2, subfamily B, polypeptide 6) | 1356 |
| CPC8 (cytochrome P450, family 2, subfamily C, polypeptide 8) | 1368 |
| CPC9 (cytochrome P450, family 2, subfamily C, polypeptide 9) | 1377 |
| CPCI (cytochrome P450, family 2, subfamily C, polypeptide 18) | 1401 |
| CPCJ (cytochrome P450, family 2, subfamily C, polypeptide 19) | 1404 |
| CPD6 (cytochrome P450, family 2, subfamily D, polypeptide 6) | 1423 |
| CPE1 (cytochrome P450, family 2, subfamily E, polypeptide 1) | 1589 |
| CPF2 (cytochrome P450, family 4, subfamily F, polypeptide 2) | 1906 |
| CPJ2 (cytochrome P450, family 2, subfamily J, polypeptide 2) | 1613 |
| CPN2 (cytochrome P450, family 11, subfamily B, polypeptide 2) | 1932 |
| CPV1 (cytochrome P450, family 19, subfamily A, polypeptide 1) | 1943 |
| CREB (cAMP responsive element binding protein 1) | 1264 |
| CREB1 (cAMP responsive element binding protein 1) | 1264 |
| CRF1 (corticotrophin releasing hormone receptor 1) | 1265 |
| CRF2 (corticotrophin releasing hormone receptor 2) | 1267 |
| CRF-R (corticotrophin releasing hormone receptor 1) | 1265 |
| CRFR1 (corticotrophin releasing hormone receptor 1) | 1265 |
| CRFR2 (corticotropin releasing hormone receptor 2) | 1267 |
| CRHR (corticotrophin releasing hormone receptor 1) | 1265 |
| CRHR1 (corticotrophin releasing hormone receptor 1) | 1265 |
| CRHR1f (corticotrophin releasing hormone receptor 1) | 1265 |
| CRH-R1h (corticotrophin releasing hormone receptor 1) | 1265 |
| CRHR2 (corticotropin releasing hormone receptor 2) | 1267 |
| CRKAS (breast cancer antiestrogen resistance 1) | 1194 |
| CRL4 (interleukin 17 receptor B) | 2221 |
| CRP (C-reactive protein, pentraxin-related) | 1267 |
| CSB (excision repair cross-complementing rodent repair deficiency, complementation group 6) | 2032 |
| CSF1R (colony stimulating factor 1 receptor) | 1270 |
| CSFR (colony stimulating factor 1 receptor) | 1270 |
| CSIF (interleukin 10) | 2213 |
| CSNK1E (casein kinase 1, epsilon) | 1272 |
| CT2 (solute carrier family 22 (organic cation/carnitine transporter), member 16) | 2411 |
| CTFgamma (amyloid beta (A4) precursor protein) | 1161 |
| CTLA4 (cytotoxic T-lymphocyte-associated protein 4) | 1273 |
| CTLA-4 (cytotoxic T-lymphocyte-associated protein 4) | 1273 |
| CTX (cytochrome P450, family 27, subfamily A, polypeptide 1) | 1979 |
| CVAP (amyloid beta (A4) precursor protein) | 1161 |
| Cw*1701 (major histocompatibility complex, class I, C) | 2135 |
| CXCR1 (interleukin 8 receptor, alpha) | 2211 |
| CXCR2 (interleukin 8 receptor, beta) | 2212 |
| CYAR (cytochrome P450, family 19, subfamily A, polypeptide 1) | 1943 |
| CYP1 (cytochrome P450, family 1, subfamily A, polypeptide 1) | 1275 |
| CYP1A1 (cytochrome P450, family 1, subfamily A, polypeptide 1) | 1275 |
| CYP1A2 (cytochrome P450, family 1, subfamily A, polypeptide 2) | 1297 |
| CYP1B1 (cytochrome P450, family 1, subfamily B, polypeptide 1) | 1335 |
| CYP2A (cytochrome P450, family 2, subfamily A, polypeptide 6) | 1347 |
| CYP2A3 (cytochrome P450, family 2, subfamily A, polypeptide 6) | 1347 |
| CYP2A6 (cytochrome P450, family 2, subfamily A, polypeptide 6) | 1347 |
| CYP2B (cytochrome P450, family 2, subfamily B, polypeptide 6) | 1356 |
| CYP2B6 (cytochrome P450, family 2, subfamily B, polypeptide 6) | 1356 |
| CYP2C (cytochrome P450, family 2, subfamily C, polypeptide 18) | 1401 |
| CYP2C (cytochrome P450, family 2, subfamily C, polypeptide 19) | 1404 |
| CYP2C (cytochrome P450, family 2, subfamily C, polypeptide 9) | 1377 |
| CYP2C8 (cytochrome P450, family 2, subfamily C, polypeptide 8) | 1368 |
| CYP2C9 (cytochrome P450, family 2, subfamily C, polypeptide 9) | 1377 |
| CYP2C9*1 (cytochrome P450, family 2, subfamily C, polypeptide 9) | 1377 |
| CYP2C9*1A (cytochrome P450, family 2, subfamily C, polypeptide 9) | 1377 |
| CYP2C10 (cytochrome P450, family 2, subfamily C, polypeptide 9) | 1377 |
| CYP2C17 (cytochrome P450, family 2, subfamily C, polypeptide 18) | 1401 |
| CYP2C18 (cytochrome P450, family 2, subfamily C, polypeptide 18) | 1401 |
| CYP2C19 (cytochrome P450, family 2, subfamily C, polypeptide 19) | 1404 |
| CYP2D (cytochrome P450, family 2, subfamily D, polypeptide 6) | 1423 |
| CYP2D@ (cytochrome P450, family 2, subfamily D, polypeptide 6) | 1423 |
| CYP2D6 (cytochrome P450, family 2, subfamily D, polypeptide 6) | 1423 |
| CYP2DL1 (cytochrome P450, family 2, subfamily D, polypeptide 6) | 1423 |
| CYP2E (cytochrome P450, family 2, subfamily E, polypeptide 1) | 1589 |
| CYP2E1 (cytochrome P450, family 2, subfamily E, polypeptide 1) | 1589 |
| CYP2J2 (cytochrome P450, family 2, subfamily J, polypeptide 2) | 1613 |
| CYP3A (cytochrome P450, family 3, subfamily A, polypeptide 4) | 1622 |
| CYP3A3 (cytochrome P450, family 3, subfamily A, polypeptide 4) | 1622 |
| CYP3A4 (cytochrome P450, family 3, subfamily A, polypeptide 4) | 1622 |
| CYP3A5 (cytochrome P450, family 3, subfamily A, polypeptide 5) | 1901 |
| CYP4B1 (cytochrome P450, family 4, subfamily B, polypeptide 1) | 1902 |
| CYP4F2 (cytochrome P450, family 4, subfamily F, polypeptide 2) | 1906 |
| CYP5 (thromboxane A synthase 1 (platelet)) | 2440 |
| CYP5A1 (thromboxane A synthase 1 (platelet)) | 2440 |
| CYP7 (cytochrome P450, family 7, subfamily A, polypeptide 1) | 1911 |
| CYP7A1 (cytochrome P450, family 7, subfamily A, polypeptide 1) | 1911 |
| CYP8 (prostaglandin I2 (prostacyclin) synthase) | 2364 |
| CYP8A1 (prostaglandin I2 (prostacyclin) synthase) | 2364 |
| CYP11B (cytochrome P450, family 11, subfamily B, polypeptide 2) | 1932 |
| CYP11B2 (cytochrome P450, family 11, subfamily B, polypeptide 2) | 1932 |
| CYP11BL (cytochrome P450, family 11, subfamily B, polypeptide 2) | 1932 |
| CYP19 (cytochrome P450, family 19, subfamily A, polypeptide 1) | 1943 |
| CYP19A1 (cytochrome P450, family 19, subfamily A, polypeptide 1) | 1943 |
| CYP27 (cytochrome P450, family 27, subfamily A, polypeptide 1) | 1979 |
| CYP27A1 (cytochrome P450, family 27, subfamily A, polypeptide 1) | 1979 |
| CYPIIB6 (cytochrome P450, family 2, subfamily B, polypeptide 6) | 1356 |
| CYPIID6 (cytochrome P450, family 2, subfamily D, polypeptide 6) | 1423 |
| CYPIVB1 (cytochrome P450, family 4, subfamily B, polypeptide 1) | 1902 |
| CYT19 (arsenic (+3 oxidation state) methyltransferase) | 1190 |
| D | |
| D2 (deiodinase, iodothyronine, type II) | 1990 |
| D2DR (dopamine receptor D2) | 1998 |
| D2R (dopamine receptor D2) | 1998 |
| D3DR (dopamine receptor D3) | 2002 |
| D4DR (dopamine receptor D4) | 2004 |
| D6S114E (transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)) | 2437 |
| D6S204 (major histocompatibility complex, class I, C) | 2135 |
| D6S1836 (opioid receptor, mu 1) | 2321 |
| D6S2650E (HLA complex P5) | 2125 |
| D11S287E (cyclin D1) | 1220 |
| D20S140E (synaptosomal-associated protein, 25kDa) | 2418 |
| D22S11 (breakpoint cluster region) | 1196 |
| D22S662 (breakpoint cluster region) | 1196 |
| D50403.1 (solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1) | 2401 |
| DAAP-57C1.5 (transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)) | 2437 |
| DADB-22N23.4 (major histocompatibility complex, class II, DP beta 1) | 2137 |
| DADB-70P7.1 (tumor necrosis factor (TNF superfamily, member 2) | 2453 |
| DADB-333F21.5 (heat shock 70kDa protein 1-like) | 2156 |
| DADR (dopamine receptor D1) | 1996 |
| DAMA-25N12.13-004 (lymphotoxin alpha (TNF superfamily, member 1)) | 2254 |
| DAQB-90C11.16 (major histocompatibility complex, class I, A) | 2129 |
| DARDARIN (leucine-rich repeat kinase 2) | 2253 |
| DAT (solute carrier family 6 (neurotransmitter transporter, dopamine), member 3) | 2395 |
| DAT1 (solute carrier family 6 (neurotransmitter transporter, dopamine), member 3) | 2395 |
| DB (leptin receptor) | 2248 |
| DBND (dystrobrevin binding protein 1) | 2008 |
| DCK (deoxycytidine kinase) | 1987 |
| DCP (angiotensin I converting enzyme (peptidyl-dipeptidase A) 1) | 1027 |
| DCP1 (angiotensin I converting enzyme (peptidyl-dipeptidase A) 1) | 1027 |
| DD4 (aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)) | 1098 |
| DDC (dopa decarboxylase (aromatic L-amino acid decarboxylase)) | 1988 |
| DDPAC (microtubule-associated protein tau) | 2261 |
| DFN7 (glutathione S-transferase pi 1) | 2113 |
| DHAM (aldehyde dehydrogenase 2 family (mitochondrial)) | 1103 |
| DHOdehase (dihydroorotate dehydrogenase) | 1989 |
| DHODH (dihydroorotate dehydrogenase) | 1989 |
| DHP (dihydropyrimidinase) | 1995 |
| DHP (dihydropyrimidine dehydrogenase) | 1993 |
| DHPASE (dihydropyrimidinase) | 1995 |
| DHPase (dihydropyrimidinase) | 1995 |
| DHPDHASE (dihydropyrimidine dehydrogenase) | 1993 |
| DHQU (NAD(P)H dehydrogenase, quinone 1) | 2306 |
| DHTR (androgen receptor) | 1183 |
| DIA4 (NAD(P)H dehydrogenase, quinone 1) | 2306 |
| DIF (tumor necrosis factor (TNF superfamily, member 2) | 2453 |
| DIO2 (deiodinase, iodothyronine, type II) | 1990 |
| DIRA (interleukin 1 receptor antagonist) | 2196 |
| dJ1068F16.2 (synaptosomal-associated protein, 25kDa) | 2418 |
| dJ127D3.1 (flavin containing monooxygenase 3) | 2067 |
| dJ221C16.10.1 (hemochromatosis) | 2126 |
| dJ261K5.1 (solute carrier family 22 (organic cation/carnitine transporter), member 16) | 2411 |
| dJ443C4.1.1 (estrogen receptor 1) | 2034 |
| dJ760C5.1 (cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)) | 1245 |
| dJ794I6.3 (inosine triphosphatase (nucleoside triphosphate pyrophosphatase)) | 2227 |
| DJS (ATP-binding cassette, sub-family C (CFTR/MRP), member 2) | 944 |
| DKFZp313P2036 (neurexin 1) | 2318 |
| DKFZp434A014 (angiotensin I converting enzyme (peptidyl-dipeptidase A) 2) | 1034 |
| DKFZp434K0220 (transient receptor potential cation channel, subfamily V, member 1) | 2478 |
| DKFZp564K192 (dystrobrevin binding protein 1) | 2008 |
| DKFZp686B1731 (leptin receptor) | 2248 |
| DKFZp686C06125 (alcohol dehydrogenase 1B (class 1), beta polypeptide) | 1053 |
| DKFZp686E0517 (solute carrier organic anion transporter family, member 2B1) | 2417 |
| DKFZp686H13163 (glutathione S-transferase omega 1) | 2111 |
| DKFZp686I24235 (cytochrome P450, family 2, subfamily C, polypeptide 18) | 1401 |
| DKFZp686L16231 (cytochrome P450, family 3, subfamily A, polypeptide 5) | 1901 |
| DKFZp686L20222 (cyclin-dependent kinase 1) | 1229 |
| DKFZp686N04233 (ATP-binding cassette, sub-family C (CFTR/MRP), member 1) | 930 |
| DKFZp686N23123 (estrogen receptor 1) | 2034 |
| DKFZp686O088 (bradykinin receptor B2) | 1197 |
| DKFZp761F1924 (regulator of G-protein signalling 4) | 2380 |
| DKFZp779B086 (alpha-2-macroglobulin) | 811 |
| DKFZp779G2333 (vascular cell adhesion molecule 1) | 2512 |
| DKFZp781G125 (ATP-binding cassette, sub-family C (CFTR/MRP), member 1) | 930 |
| DKFZp781N0678 (IMP (inosine monophosphate) dehydrogenase 1) | 2222 |
| DP2 (adenomatous polyposis coli) | 1112 |
| DP2.5 (adenomatous polyposis coli) | 1112 |
| DP3 (adenomatous polyposis coli) | 1112 |
| DPB1 (major histocompatibility complex, class II, DP beta 1) | 2137 |
| DPD (dihydropyrimidine dehydrogenase) | 1993 |
| DPD1 (transforming growth factor, beta 1) | 2442 |
| DPP4 (dipeptidyl-peptidase 4) | 1992 |
| DPP IV (dipeptidyl-peptidase 4) | 1992 |
| DPPIV (dipeptidyl-peptidase 4) | 1992 |
| DPYD (dihydropyrimidine dehydrogenase) | 1993 |
| DPYS (dihydropyrimidinase) | 1995 |
| DQ-A1 (major histocompatibility complex, class II, DQ alpha 1) | 2139 |
| DRB1 (major histocompatibility complex, class II, DR beta 1) | 2141 |
| DRD1 (dopamine receptor D1) | 1996 |
| DRD1A (dopamine receptor D1) | 1996 |
| DRD1B (dopamine receptor D5) | 2006 |
| DRD1L2 (dopamine receptor D5) | 2006 |
| DRD2 (dopamine receptor D2) | 1998 |
| DRD3 (dopamine receptor D3) | 2002 |
| DRD4 (dopamine receptor D4) | 2004 |
| DRD5 (dopamine receptor D5) | 2006 |
| DRw10 (major histocompatibility complex, class II, DR beta 1) | 2141 |
| DSMAX (ATPase, Cu++ transporting, alpha polypeptide) | 1192 |
| DTD (NAD(P)H dehydrogenase, quinone 1) | 2306 |
| DTNBP1 (dystrobrevin binding protein 1) | 2008 |
| DYT5 (GTP cyclohydrolase 1) | 2079 |
| DYT5a (GTP cyclohydrolase 1) | 2079 |
| DYT14 (GTP cyclohydrolase 1) | 2079 |
| E | |
| E1 (butyrylcholinesterase) | 1194 |
| EAA1 (glutamate receptor, ionotropic, kainate 4) | 2096 |
| EAA4 (glutamate receptor, ionotropic, kainate 2) | 2095 |
| EBN (cholinergic receptor, nicotinic, alpha 4) | 1253 |
| EBN1 (cholinergic receptor, nicotinic, alpha 4) | 1253 |
| EC 2.5.1.18 (glutathione S-transferase pi 1) | 2113 |
| EC1.14.14.1 (cytochrome P450, family 2, subfamily D, polypeptide 6) | 1423 |
| EC-SOD (superoxide dismutase 3, extracellular) | 2424 |
| ECNOS (nitric oxide synthase 3 (endothelial cell)) | 2298 |
| EDH17B2 (hydroxysteroid (17-beta) dehydrogenase 1) | 2156 |
| EDHB17 (hydroxysteroid (17-beta) dehydrogenase 1) | 2156 |
| EDN1 (endothelin 1) | 2011 |
| EDNRA (endothelin receptor type A) | 2013 |
| EDTP308 (vitamin K epoxide reductase complex, subunit 1) | 2520 |
| EGFR (epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)) | 2015 |
| EIG8 (calcium-sensing receptor) | 1211 |
| EM9 (excision repair cross-complementing rodent repair deficiency, complementation group 2) | 2029 |
| ENaCg (sodium channel, nonvoltage-gated 1, gamma) | 2391 |
| ENaCgamma (sodium channel, nonvoltage-gated 1, gamma) | 2391 |
| ENFL3 (cholinergic receptor, nicotinic, beta 2 (neuronal)) | 1255 |
| eNOS (nitric oxide synthase 3 (endothelial cell)) | 2298 |
| EP1 (prostaglandin E receptor 1 (subtype EP1), 42kDa) | 2359 |
| EP2 (prostaglandin E receptor 2 (subtype EP2), 53kDa) | 2359 |
| EP3 (prostaglandin E receptor 3 (subtype EP3)) | 2360 |
| EP3e (prostaglandin E receptor 3 (subtype EP3)) | 2360 |
| EP3-I (prostaglandin E receptor 3 (subtype EP3)) | 2360 |
| EP3-II (prostaglandin E receptor 3 (subtype EP3)) | 2360 |
| EP3-III (prostaglandin E receptor 3 (subtype EP3)) | 2360 |
| EP3-IV (prostaglandin E receptor 3 (subtype EP3)) | 2360 |
| EP4 (prostaglandin E receptor 4 (subtype EP4)) | 2361 |
| EP4R (prostaglandin E receptor 4 (subtype EP4)) | 2361 |
| EPHX (epoxide hydrolase 1, microsomal (xenobiotic)) | 2020 |
| EPHX1 (epoxide hydrolase 1, microsomal (xenobiotic)) | 2020 |
| EPOX (epoxide hydrolase 1, microsomal (xenobiotic)) | 2020 |
| ER (estrogen receptor 1) | 2034 |
| Era (estrogen receptor 1) | 2034 |
| ERAAP (endoplasmic reticulum aminopeptidase 1) | 2022 |
| ERAAP1 (endoplasmic reticulum aminopeptidase 1) | 2022 |
| ER-alpha (estrogen receptor 1) | 2034 |
| ERAP1 (endoplasmic reticulum aminopeptidase 1) | 2022 |
| Erb (estrogen receptor 2 (ER beta)) | 2042 |
| ERBB (epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)) | 2015 |
| ERBB1 (epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)) | 2015 |
| ERBB2 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)) | 2023 |
| ERBB4 (v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian)) | 2026 |
| ER-BETA (estrogen receptor 2 (ER beta)) | 2042 |
| ERCC1 (excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)) | 2028 |
| ERCC2 (excision repair cross-complementing rodent repair deficiency, complementation group 2) | 2029 |
| ERCC6 (excision repair cross-complementing rodent repair deficiency, complementation group 6) | 2032 |
| ERG1 (potassium voltage-gated channel, subfamily H (eag-related), member 2) | 2230 |
| ERK4 (mitogen-activated protein kinase 7) | 2261 |
| ERK5 (mitogen-activated protein kinase 7) | 2261 |
| ESA (paraoxonase 1) | 2335 |
| ESR (estrogen receptor 1) | 2034 |
| ESR1 (estrogen receptor 1) | 2034 |
| ESR2 (estrogen receptor 2 (ER beta)) | 2042 |
| ESRA (estrogen receptor 1) | 2034 |
| ESRB (estrogen receptor 2 (ER beta)) | 2042 |
| ESR-BETA (estrogen receptor 2 (ER beta)) | 2042 |
| EST (sulfotransferase family 1E, estrogen-preferring, member 1) | 2435 |
| EST1 (carboxylesterase 1 (monocyte/macrophage serine esterase 1)) | 1241 |
| EST-1 (sulfotransferase family 1E, estrogen-preferring, member 1) | 2435 |
| EST2 (telomerase reverse transcriptase) | 2440 |
| EST90757 (ATP-binding cassette, sub-family C (CFTR/MRP), member 3) | 963 |
| EST157481 (ATP-binding cassette, sub-family G (WHITE), member 2) | 996 |
| EST170205 (ATP-binding cassette, sub-family C (CFTR/MRP), member 4) | 965 |
| EST349056 (ATP-binding cassette, sub-family C (CFTR/MRP), member 6) | 971 |
| ESTRB (estrogen receptor 2 (ER beta)) | 2042 |
| ET-1 (endothelin 1) | 2011 |
| ETA (endothelin receptor type A) | 2013 |
| ETAR (endothelin receptor type A) | 2013 |
| ETHA (sodium channel, voltage-gated, type IX, alpha subunit) | 2390 |
| ETRA (endothelin receptor type A) | 2013 |
| EVI27 (interleukin 17 receptor B) | 2221 |
| EVI80 (v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) | 2239 |
| F | |
| F2 (coagulation factor II (thrombin)) | 2047 |
| F5 (coagulation factor V (proaccelerin, labile factor)) | 2049 |
| F7 (coagulation factor VII (serum prothrombin conversion accelerator)) | 2050 |
| FAAR (peroxisome proliferator-activated receptor delta) | 2340 |
| FABL (fatty acid binding protein 1, liver) | 2052 |
| FABP1 (fatty acid binding protein 1, liver) | 2052 |
| FABP2 (fatty acid binding protein 2, intestinal) | 2053 |
| FABPI (fatty acid binding protein 2, intestinal) | 2053 |
| FABPL (fatty acid binding protein 1, liver) | 2052 |
| FACD (breast cancer 2, early onset) | 1208 |
| FACL1 (acyl-CoA synthetase long-chain family member 1) | 1042 |
| FACL2 (acyl-CoA synthetase long-chain family member 1) | 1042 |
| FACL3 (acyl-CoA synthetase long-chain family member 3) | 1043 |
| FACL4 (acyl-CoA synthetase long-chain family member 4) | 1044 |
| FACL5 (acyl-CoA synthetase long-chain family member 5) | 1045 |
| FACL6 (acyl-CoA synthetase long-chain family member 6) | 1046 |
| FAD (breast cancer 2, early onset) | 1208 |
| FAD (presenilin 1) | 2353 |
| FAD1 (breast cancer 2, early onset) | 1208 |
| FAEES3 (glutathione S-transferase pi 1) | 2113 |
| FANCD (breast cancer 2, early onset) | 1208 |
| FANCD1 (breast cancer 2, early onset) | 1208 |
| FAP (adenomatous polyposis coli) | 1112 |
| FCC1 (mutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli)) | 2278 |
| FCC2 (mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli)) | 2272 |
| FCCMS (cholinergic receptor, nicotinic, alpha 1 (muscle)) | 1252 |
| FCE2 (Fc fragment of IgE, low affinity II, receptor for (CD23)) | 2054 |
| FCER2 (Fc fragment of IgE, low affinity II, receptor for (CD23)) | 2054 |
| FCG2 (Fc fragment of IgG, low affinity IIa, receptor (CD32)) | 2055 |
| FCG2A (Fc fragment of IgG, low affinity IIa, receptor (CD32)) | 2055 |
| FCG3 (Fc fragment of IgG, low affinity IIIa, receptor (CD16a)) | 2057 |
| FcgammaRIIIA (Fc fragment of IgG, low affinity IIIa, receptor (CD16a)) | 2057 |
| FcGR (Fc fragment of IgG, low affinity IIa, receptor (CD32)) | 2055 |
| FCGR2 (Fc fragment of IgG, low affinity IIa, receptor (CD32)) | 2055 |
| FCGR2A (Fc fragment of IgG, low affinity IIa, receptor (CD32)) | 2055 |
| FCGR2A1 (Fc fragment of IgG, low affinity IIa, receptor (CD32)) | 2055 |
| FCGR3 (Fc fragment of IgG, low affinity IIIa, receptor (CD16a)) | 2057 |
| FCGR3A (Fc fragment of IgG, low affinity IIIa, receptor (CD16a)) | 2057 |
| FCGRIII (Fc fragment of IgG, low affinity IIIa, receptor (CD16a)) | 2057 |
| FcR-10 (Fc fragment of IgG, low affinity IIIa, receptor (CD16a)) | 2057 |
| FCR2 (Fc fragment of IgG, low affinity IIa, receptor (CD32)) | 2055 |
| FcRIII (Fc fragment of IgG, low affinity IIIa, receptor (CD16a)) | 2057 |
| FcRIIIa (Fc fragment of IgG, low affinity IIIa, receptor (CD16a)) | 2057 |
| FEB3 (sodium channel, voltage-gated, type I, alpha subunit) | 2385 |
| FEB3B (sodium channel, voltage-gated, type IX, alpha subunit) | 2390 |
| FET1 (dopamine receptor D3) | 2002 |
| FGB (fibrinogen beta chain) | 2059 |
| FGQTL2 (melatonin receptor 1B) | 2289 |
| FH (complement factor H) | 1244 |
| FH (low density lipoprotein receptor) | 2243 |
| FHC (low density lipoprotein receptor) | 2243 |
| FHH (calcium-sensing receptor) | 1211 |
| FHL1 (complement factor H) | 1244 |
| FIH (calcium-sensing receptor) | 1211 |
| FIM2 (colony stimulating factor 1 receptor) | 1270 |
| FIMG2 (choline O-acetyltransferase) | 1248 |
| FIP (upstream transcription factor 2, c-fos interacting) | 2510 |
| FKBP5 (FK506 binding protein 5) | 2061 |
| FKBP51 (FK506 binding protein 5) | 2061 |
| FKBP54 (FK506 binding protein 5) | 2061 |
| FLDB (apolipoprotein B (including Ag(x) antigen)) | 1118 |
| FLIPT2 (solute carrier family 22 (organic cation/carnitine transporter), member 16) | 2411 |
| FLJ00289 (vitamin K epoxide reductase complex, subunit 1) | 2520 |
| FLJ10761 (renin) | 2377 |
| FLJ12046 (adenylate cyclase 9) | 1049 |
| FLJ14958 (ATP-binding cassette, sub-family A (ABC1), member 1) | 812 |
| FLJ16167 (solute carrier family 14 (urea transporter), member 2) | 2402 |
| FLJ16173 (acyl-CoA synthetase long-chain family member 6) | 1046 |
| FLJ16453 (breakpoint cluster region) | 1196 |
| FLJ17790 (ATPase, Cu++ transporting, alpha polypeptide) | 1192 |
| FLJ18426 (potassium voltage-gated channel, Isk-related family, member 1) | 2228 |
| FLJ20882 (signal transducer and activator of transcription 3 (acute-phase response factor)) | 2428 |
| FLJ21468 (solute carrier family 28 (sodium-coupled nucleoside transporter), member 2) | 2413 |
| FLJ22066 (insulin-like growth factor 2 (somatomedin A)) | 2189 |
| FLJ23079 (synaptosomal-associated protein, 25kDa) | 2418 |
| FLJ26167 (potassium voltage-gated channel, KQT-like subfamily, member 1) | 2234 |
| FLJ26629 (gamma-glutamyl carboxylase) | 2082 |
| FLJ26655 (major histocompatibility complex, class I, A) | 2129 |
| FLJ26666 (transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)) | 2437 |
| FLJ27082 (major histocompatibility complex, class I, C) | 2135 |
| FLJ27088 (major histocompatibility complex, class II, DQ alpha 1) | 2139 |
| FLJ27114 (polymerase (DNA directed), gamma) | 2333 |
| FLJ27328 (major histocompatibility complex, class II, DQ alpha 1) | 2139 |
| FLJ30031 (dystrobrevin binding protein 1) | 2008 |
| FLJ31317 (cytochrome P450, family 3, subfamily A, polypeptide 5) | 1901 |
| FLJ31424 (microtubule-associated protein tau) | 2261 |
| FLJ33168 (5-methyltetrahydrofolate-homocysteine methyltransferase) | 2290 |
| FLJ33407 (solute carrier family 15 (H+/peptide transporter), member 2) | 2404 |
| FLJ35941 (neurexin 1) | 2318 |
| FLJ37295 (tryptophan hydroxylase 2) | 2475 |
| FLJ37308 (spastic paraplegia 7 (pure and complicated autosomal recessive)) | 2425 |
| FLJ38123 (potassium voltage-gated channel, Isk-related family, member 1) | 2228 |
| FLJ39654 (hepatocyte nuclear factor 4, alpha) | 2147 |
| FLJ40826 (flavin containing monooxygenase 2 (non-functional)) | 2066 |
| FLJ41437 (calcium channel, voltage-dependent, gamma-2 subunit) | 1210 |
| FLJ41500 (transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)) | 2437 |
| FLJ41585 (bone morphogenetic protein receptor, type II (serine/threonine kinase)) | 1202 |
| FLJ43216 (5-methyltetrahydrofolate-homocysteine methyltransferase) | 2290 |
| FLJ43243 (cholinergic receptor, muscarinic 2) | 1250 |
| FLJ44734 (insulin-like growth factor 2 (somatomedin A)) | 2189 |
| FLJ45059 (breast cancer anti-estrogen resistance 1) | 1194 |
| FLJ45386 (5-methyltetrahydrofolate-homocysteine methyltransferase) | 2290 |
| FLJ52771 (thromboxane A synthase 1 (platelet)) | 2440 |
| FLJ55736 (solute carrier family 22 (organic anion transporter), member 6) | 2408 |
| FLJ75017 (major histocompatibility complex, class II, DR beta 1) | 2141 |
| FLJ76359 (major histocompatibility complex, class II, DR beta 1) | 2141 |
| FLJ76945 (bone morphogenetic protein receptor, type II (serine/threonine kinase)) | 1202 |
| FLJ78003 (chemokine (C-C motif) receptor 5) | 1223 |
| FLJ90608 (calumenin) | 1210 |
| FLJ92595 (angiotensinogen (serpin peptidase inhibitor, clade A, member 8)) | 1083 |
| FLJ92943 (tumor protein p53) | 2468 |
| FLJ93545 (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase) | 1191 |
| FLJ94103 (potassium voltage-gated channel, Isk-related family, member 1) | 2228 |
| FLJ94114 (leptin) | 2246 |
| FLJ95109 (v-raf murine sarcoma viral oncogene homolog B1) | 1203 |
| FLJ95812 (cholinergic receptor, nicotinic, alpha 4) | 1253 |
| FLJ96318 (solute carrier family 12 (sodium/chloride transporters), member 3) | 2402 |
| FLJ97926 (angiotensinogen (serpin peptidase inhibitor, clade A, member 8)) | 1083 |
| FLJ97995 (apolipoprotein A-V) | 1116 |
| FLJ98532 (Niemann-Pick disease, type C1) | 2303 |
| FLJ99960 (adrenergic, beta-3-, receptor) | 1080 |
| FLK1 (kinase insert domain receptor (a type III receptor tyrosine kinase)) | 2236 |
| FLK2 (fms-related tyrosine kinase 3) | 2062 |
| FLT3 (fms-related tyrosine kinase 3) | 2062 |
| FMO1 (flavin containing monooxygenase 1) | 2064 |
| FMO1B1 (flavin containing monooxygenase 2 (non-functional)) | 2066 |
| FMO2 (flavin containing monooxygenase 2 (non-functional)) | 2066 |
| FMO3 (flavin containing monooxygenase 3) | 2067 |
| FMOII (flavin containing monooxygenase 3) | 2067 |
| FMR1 (fragile X mental retardation 1) | 2068 |
| FMRP (fragile X mental retardation 1) | 2068 |
| FMS (colony stimulating factor 1 receptor) | 1270 |
| FOLT (solute carrier family 19 (folate transporter), member 1) | 2404 |
| FOS (FBJ murine osteosarcoma viral oncogene homolog) | 2069 |
| FP (prostaglandin F receptor (FP)) | 2363 |
| FPC (adenomatous polyposis coli) | 1112 |
| FPF (tumor necrosis factor receptor superfamily, member 1A) | 2464 |
| FRAXA (fragile X mental retardation 1) | 2068 |
| FSHR (follicle stimulating hormone receptor) | 2074 |
| FSHRO (follicle stimulating hormone receptor) | 2074 |
| FTDP-17 (microtubule-associated protein tau) | 2261 |
| FVL (coagulation factor V (proaccelerin, labile factor)) | 2049 |
| FWP007 (alpha-2-macroglobulin) | 811 |
| G | |
| G0S8 (regulator of G-protein signaling 2, 24kDa) | 2379 |
| G6PD (glucose-6-phosphate dehydrogenase) | 2076 |
| G6PD1 (glucose-6-phosphate dehydrogenase) | 2076 |
| GABRA6 (gamma-aminobutyric acid (GABA) A receptor, alpha 6) | 2078 |
| GBP28 (adiponectin, C1Q and collagen domain containing) | 1056 |
| GCCR (nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)) | 2314 |
| GCH (GTP cyclohydrolase 1) | 2079 |
| GCH1 (GTP cyclohydrolase 1) | 2079 |
| GCR (nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)) | 2314 |
| GEFSP1 (sodium channel, voltage-gated, type I, beta) | 2386 |
| GEFSP2 (sodium channel, voltage-gated, type I, alpha subunit) | 2385 |
| GGCX (gamma-glutamyl carboxylase) | 2082 |
| GGH (gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase)) | 2083 |
| GH (gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase)) | 2083 |
| GH (growth hormone 1) | 2085 |
| GH1 (growth hormone 1) | 2085 |
| GH-N (growth hormone 1) | 2085 |
| GHBP (growth hormone receptor) | 2086 |
| GHN (growth hormone 1) | 2085 |
| GHOSAL (thromboxane A synthase 1 (platelet)) | 2440 |
| GHR (growth hormone receptor) | 2086 |
| GLBP28 (adiponectin, C1Q and collagen domain containing) | 1056 |
| GLC3A (cytochrome P450, family 1, subfamily B, polypeptide 1) | 1335 |
| GLM3 (breast cancer 2, early onset) | 1208 |
| GLR6 (glutamate receptor, ionotropic, kainate 2) | 2095 |
| GLUK6 (glutamate receptor, ionotropic, kainate 2) | 2095 |
| GLUR-C (glutamate receptor, ionotrophic, AMPA 3) | 2093 |
| GLUR-K3 (glutamate receptor, ionotrophic, AMPA 3) | 2093 |
| GLUR3 (glutamate receptor, metabotropic 3) | 2098 |
| GLUR3 (glutamate receptor, ionotrophic, AMPA 3) | 2093 |
| GLUR6 (glutamate receptor, ionotropic, kainate 2) | 2095 |
| GLURC (glutamate receptor, ionotrophic, AMPA 3) | 2093 |
| GNAS (GNAS complex locus) | 2089 |
| GNAS1 (GNAS complex locus) | 2089 |
| GNB3 (guanine nucleotide binding protein (G protein), beta polypeptide 3) | 2091 |
| GNT1 (UDP glucuronosyltransferase 1 family, polypeptide A6) | 2495 |
| GNT1 (UDP glucuronosyltransferase 1 family, polypeptide A1) | 2483 |
| GNT1 (UDP glucuronosyltransferase 1 family, polypeptide A3) | 2490 |
| GP3A (integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)) | 2225 |
| GP91-2 (NADPH oxidase 1) | 2302 |
| GP145-TrkB (neurotrophic tyrosine kinase, receptor, type 2) | 2318 |
| GP170 (ATP-binding cassette, sub-family B (MDR/TAP), member 1) | 824 |
| GPla (integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)) | 2224 |
| GPIIIa (integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)) | 2225 |
| GPRC1C (glutamate receptor, metabotropic 3) | 2098 |
| GPRC2A (calcium-sensing receptor) | 1211 |
| GPRK5 (G protein-coupled receptor kinase 5) | 2097 |
| GPSA (GNAS complex locus) | 2089 |
| GR (nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)) | 2314 |
| GRIA3 (glutamate receptor, ionotrophic, AMPA 3) | 2093 |
| GRIK (glutamate receptor, ionotropic, kainate 4) | 2096 |
| GRIK2 (glutamate receptor, ionotropic, kainate 2) | 2095 |
| GRIK4 (glutamate receptor, ionotropic, kainate 4) | 2096 |
| GRINA (glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding)) | 2097 |
| GRIPGHS (prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)) | 2367 |
| GRK5 (G protein-coupled receptor kinase 5) | 2097 |
| GRL (nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)) | 2314 |
| GRM3 (glutamate receptor, metabotropic 3) | 2098 |
| GS (adenomatous polyposis coli) | 1112 |
| GSA (GNAS complex locus) | 2089 |
| GSE (cytotoxic T-lymphocyte-associated protein 4) | 1273 |
| GSE (major histocompatibility complex, class II, DQ alpha 1) | 2139 |
| GSHS (glutathione synthetase) | 2102 |
| GSK3 (glycogen synthase kinase 3 beta) | 2099 |
| GSK3B (glycogen synthase kinase 3 beta) | 2099 |
| GSP (GNAS complex locus) | 2089 |
| GSS (glutathione synthetase) | 2102 |
| GSS (prion protein) | 2347 |
| GST (glutathione S-transferase kappa 1) | 2106 |
| GST1 (glutathione S-transferase mu 1) | 2107 |
| GST2 (glutathione S-transferase alpha 1) | 2104 |
| GST3 (glutathione S-transferase pi 1) | 2113 |
| GST13 (glutathione S-transferase kappa 1) | 2106 |
| GST13-13 (glutathione S-transferase kappa 1) | 2106 |
| GSTA1 (glutathione S-transferase alpha 1) | 2104 |
| GSTA1-1 (glutathione S-transferase alpha 1) | 2104 |
| GST-epsilon (glutathione S-transferase alpha 1) | 2104 |
| GSTK1 (glutathione S-transferase kappa 1) | 2106 |
| GSTK1-1 (glutathione S-transferase kappa 1) | 2106 |
| GSTM1 (glutathione S-transferase mu 1) | 2107 |
| GSTM1-1 (glutathione S-transferase mu 1) | 2107 |
| GSTM1a-1a (glutathione S-transferase mu 1) | 2107 |
| GSTM1b-1b (glutathione S-transferase mu 1) | 2107 |
| GSTO1 (glutathione S-transferase omega 1) | 2111 |
| GSTO2 (glutathione S-transferase omega 2) | 2113 |
| GSTP1 (glutathione S-transferase pi 1) | 2113 |
| GSTP1-1 (glutathione S-transferase pi 1) | 2113 |
| GSTT1 (glutathione S-transferase theta 1) | 2118 |
| GSTTLp28 (glutathione S-transferase omega 1) | 2111 |
| GS-X (ATP-binding cassette, sub-family C (CFTR/MRP), member 1) | 930 |
| GTH1 (glutathione S-transferase alpha 1) | 2104 |
| GTH4 (glutathione S-transferase mu 1) | 2107 |
| GTM1 (glutathione S-transferase mu 1) | 2107 |
| GTP-CH-1 (GTP cyclohydrolase 1) | 2079 |
| GTPCH1 (GTP cyclohydrolase 1) | 2079 |
| H | |
| H1-R (histamine receptor H1) | 2153 |
| H2R (histamine receptor H2) | 2155 |
| hA2aR (adenosine A2a receptor) | 1060 |
| HAKRA (aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)) | 1098 |
| HAST (sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3) | 2433 |
| HAST1/HAST2 (sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1) | 2431 |
| HAST3 (sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3) | 2433 |
| HAST4 (sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2) | 2432 |
| HAT1R (angiotensin II receptor, type 1) | 1088 |
| HB1 (sodium channel, voltage-gated, type V, alpha subunit) | 2388 |
| HB2 (sodium channel, voltage-gated, type V, alpha subunit) | 2388 |
| HBA (sodium channel, voltage-gated, type II, alpha subunit) | 2386 |
| HBB (hemoglobin, beta) | 2122 |
| HBBD (sodium channel, voltage-gated, type V, alpha subunit) | 2388 |
| HBD (hemoglobin, beta) | 2122 |
| HBSCI (sodium channel, voltage-gated, type I, alpha subunit) | 2385 |
| HBSCI (sodium channel, voltage-gated, type II, alpha subunit) | 2386 |
| HBSCII (sodium channel, voltage-gated, type II, alpha subunit) | 2386 |
| Hcam3 (phosphodiesterase 1C, calmodulin-dependent 70kDa) | 2327 |
| hCBR1 (carbonyl reductase 1) | 1217 |
| hCBR3 (carbonyl reductase 3) | 1218 |
| hCG_1980470 (breast cancer anti-estrogen resistance 1) | 1194 |
| HCKIE (casein kinase 1, epsilon) | 1272 |
| HCNT1 (solute carrier family 28 (sodium-coupled nucleoside transporter), member 1) | 2412 |
| HCNT2 (solute carrier family 28 (sodium-coupled nucleoside transporter), member 2) | 2413 |
| hCox-2 (prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)) | 2367 |
| HCP5 (HLA complex P5) | 2125 |
| HD (huntingtin) | 2170 |
| HDLCQ7 (endothelin 1) | 2011 |
| HDLCQ10 (cholesteryl ester transfer protein, plasma) | 1243 |
| HDLCQ12 (lipase, hepatic) | 2249 |
| HDLCQ13 (ATP-binding cassette, sub-family A (ABC1), member 1) | 812 |
| HDLDT1 (ATP-binding cassette, sub-family A (ABC1), member 1) | 812 |
| HER1 (epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)) | 2015 |
| HER-2 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)) | 2023 |
| HER2 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)) | 2023 |
| HER-2/neu (v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)) | 2023 |
| HER4 (v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian)) | 2026 |
| HERG (potassium voltage-gated channel, subfamily H (eag-related), member 2) | 2230 |
| HERG1 (potassium voltage-gated channel, subfamily H (eag-related), member 2) | 2230 |
| hEST2 (telomerase reverse transcriptase) | 2440 |
| HF (complement factor H) | 1244 |
| HF1 (complement factor H) | 1244 |
| HF2 (complement factor H) | 1244 |
| HFE (hemochromatosis) | 2126 |
| HFE1 (hemochromatosis) | 2126 |
| HGF (interleukin 6 (interferon, beta 2)) | 2204 |
| HGFR (met proto-oncogene (hepatocyte growth factor receptor) | 2269 |
| hGH-N (growth hormone 1) | 2085 |
| HH (hemochromatosis) | 2126 |
| HH1 (sodium channel, voltage-gated, type V, alpha subunit) | 2388 |
| HHC (calcium-sensing receptor) | 1211 |
| HHC1 (calcium-sensing receptor) | 1211 |
| HHF1 (ATP-binding cassette, sub-family C (CFTR/MRP), member 8) | 979 |
| HHF2 (potassium inwardly-rectifying channel, subfamily J, member 11) | 2232 |
| HHT (activin A receptor, type II-like 1) | 1046 |
| HHT2 (activin A receptor, type II-like 1) | 1046 |
| HI (ATP-binding cassette, sub-family C (CFTR/MRP), member 8) | 979 |
| HIES (signal transducer and activator of transcription 3 (acute-phase response factor)) | 2428 |
| HIP4 (cystathionine beta-synthase) | 1219 |
| hisH1 (histamine receptor H1) | 2153 |
| HL (lipase, hepatic) | 2249 |
| HLA-A (major histocompatibility complex, class I, A) | 2129 |
| HLAA (major histocompatibility complex, class I, A) | 2129 |
| HLAB (major histocompatibility complex, class I, B) | 2131 |
| HLA-B (major histocompatibility complex, class I, B) | 2131 |
| HLA-B27 (major histocompatibility complex, class I, B) | 2131 |
| HLA-B73 (major histocompatibility complex, class I, B) | 2131 |
| HLA-B-7301 (major histocompatibility complex, class I, B) | 2131 |
| HLA-C (major histocompatibility complex, class I, C) | 2135 |
| HLAC (major histocompatibility complex, class I, B) | 2131 |
| HLA-Cw (major histocompatibility complex, class I, C) | 2135 |
| HLA-Cw12 (major histocompatibility complex, class I, C) | 2135 |
| HLA-DP1B (major histocompatibility complex, class II, DP beta 1) | 2137 |
| HLA-DPB1 (major histocompatibility complex, class II, DP beta 1) | 2137 |
| HLA-DQA (major histocompatibility complex, class II, DQ alpha 1) | 2139 |
| HLA-DQA1 (major histocompatibility complex, class II, DQ alpha 1) | 2139 |
| HLA-DR1B (major histocompatibility complex, class II, DR beta 1) | 2141 |
| HLA-DRB (major histocompatibility complex, class II, DR beta 1) | 2141 |
| HLA-DRB1 (major histocompatibility complex, class II, DR beta 1) | 2141 |
| HLA-DRB1* (major histocompatibility complex, class II, DR beta 1) | 2141 |
| HLA-H (hemochromatosis) | 2126 |
| HLA-JY3 (major histocompatibility complex, class I, C) | 2135 |
| HLC14-06-P (inosine triphosphatase (nucleoside triphosphate pyrophosphatase)) | 2227 |
| HLC-C (major histocompatibility complex, class I, C) | 2135 |
| HLP (cytochrome P450, family 3, subfamily A, polypeptide 4) | 1622 |
| HLUG4 (UDP glucuronosyltransferase 2 family, polypeptide B15) | 2509 |
| HLUGP (UDP glucuronosyltransferase 1 family, polypeptide A6) | 2495 |
| HLUGP1 (UDP glucuronosyltransferase 1 family, polypeptide A6) | 2495 |
| HLUGP4 (UDP glucuronosyltransferase 1 family, polypeptide A9) | 2500 |
| HM1 (cholinergic receptor, muscarinic 1) | 1249 |
| HM2 (cholinergic receptor, muscarinic 2) | 1250 |
| HM3 (cholinergic receptor, muscarinic 3) | 1251 |
| HMGCR (3-hydroxy-3-methylglutaryl-Coenzyme A reductase) | 2145 |
| hMLH1 (mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli)) | 2272 |
| HMSE (carboxylesterase 1 (monocyte/macrophage serine esterase 1)) | 1241 |
| HMSE1 (carboxylesterase 1 (monocyte/macrophage serine esterase 1)) | 1241 |
| HNF4 (hepatocyte nuclear factor 4, alpha) | 2147 |
| HNF4A (hepatocyte nuclear factor 4, alpha) | 2147 |
| HNF4a7 (hepatocyte nuclear factor 4, alpha) | 2147 |
| HNF4a8 (hepatocyte nuclear factor 4, alpha) | 2147 |
| HNF4a9 (hepatocyte nuclear factor 4, alpha) | 2147 |
| HNF4alpha (hepatocyte nuclear factor 4, alpha) | 2147 |
| HNFJ2 (renin) | 2377 |
| HNPCC (mutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli)) | 2278 |
| HNPCC (mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli)) | 2272 |
| HNPCC1 (mutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli)) | 2278 |
| HNPCC2 (mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli)) | 2272 |
| HNRGW (glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding)) | 2097 |
| HOAT1 (solute carrier family 22 (organic anion transporter), member 6) | 2408 |
| HOCT1 (solute carrier family 22 (organic cation transporter), member 1) | 2406 |
| HOKPP2 (sodium channel, voltage-gated, type IV, alpha subunit) | 2387 |
| HORK3 (purinergic receptor P2Y, G-protein coupled, 12) | 2324 |
| HOXB13 (homeobox B13) | 2150 |
| HP (haptoglobin) | 2152 |
| HP2-ALPHA-2 (haptoglobin) | 2152 |
| HP2ALPHA2 (haptoglobin) | 2152 |
| HPA1S (haptoglobin) | 2152 |
| HPABH4B (GTP cyclohydrolase 1) | 2079 |
| HPECT1 (solute carrier family 15 (oligopeptide transporter), member 1) | 2403 |
| HPEPT1 (solute carrier family 15 (oligopeptide transporter), member 1) | 2403 |
| HPPAR (peroxisome proliferator-activated receptor alpha) | 2338 |
| hppar (peroxisome proliferator-activated receptor alpha) | 2338 |
| HPS7 (dystrobrevin binding protein 1) | 2008 |
| HRH1 (histamine receptor H1) | 2153 |
| HRH2 (histamine receptor H2) | 2155 |
| HRINS (ATP-binding cassette, sub-family C (CFTR/MRP), member 8) | 979 |
| Hs.22998 (neurexin 1) | 2318 |
| HSAN2 (WNK lysine deficient protein kinase 1) | 2522 |
| HSCR1 (ret proto-oncogene) | 2377 |
| HSD (carbohydrate (chondroitin 6) sulfotransferase 3) | 1256 |
| HSD17 (hydroxysteroid (17-beta) dehydrogenase 1) | 2156 |
| HSD17B1 (hydroxysteroid (17-beta) dehydrogenase 1) | 2155 |
| hSERT (solute carrier family 6 (neurotransmitter transporter, serotonin), member 4) | 2397 |
| HSF (interleukin 6 (interferon, beta 2)) | 2204 |
| HSMRK222 (TIMP metallopeptidase inhibitor 3) | 2450 |
| HSN2 (WNK lysine deficient protein kinase 1) | 2522 |
| HSP70-1L (heat shock 70kDa protein 1-like) | 2156 |
| HSP70-HOM (heat shock 70kDa protein 1-like) | 2156 |
| HSP70T (heat shock 70kDa protein 1-like) | 2156 |
| HSPA1L (heat shock 70kDa protein 1-like) | 2156 |
| HST422 (thymidylate synthetase) | 2479 |
| HsT17153 (solute carrier family 28 (sodium-coupled nucleoside transporter), member 2) | 2413 |
| HT1DA (5-hydroxytryptamine (serotonin) receptor 1D) | 2161 |
| HTGL (lipase, hepatic) | 2249 |
| hToll (toll-like receptor 4) | 2451 |
| HTR1A (5-hydroxytryptamine (serotonin) receptor 1A) | 2157 |
| HTR1B (5-hydroxytryptamine (serotonin) receptor 1B) | 2159 |
| HTR1C (5-hydroxytryptamine (serotonin) receptor 2C) | 2164 |
| HTR1D (5-hydroxytryptamine (serotonin) receptor 1D) | 2161 |
| HTR1D2 (5-hydroxytryptamine (serotonin) receptor 1B) | 2159 |
| HTR1DA (5-hydroxytryptamine (serotonin) receptor 1D) | 2161 |
| HTR1DB (5-hydroxytryptamine (serotonin) receptor 1B) | 2159 |
| HTR2 (5-hydroxytryptamine (serotonin) receptor 2A) | 2161 |
| HTR2A (5-hydroxytryptamine (serotonin) receptor 2A) | 2161 |
| HTR2C (5-hydroxytryptamine (serotonin) receptor 2C) | 2164 |
| HTR3 (5-hydroxytryptamine (serotonin) receptor 3A) | 2165 |
| HTR3A (5-hydroxytryptamine (serotonin) receptor 3A) | 2165 |
| HTR3B (5-hydroxytryptamine (serotonin) receptor 3B) | 2168 |
| HTR3C (5-hydroxytryptamine (serotonin) receptor 3, family member C) | 2169 |
| HTR6 (5-hydroxytryptamine (serotonin) receptor 6) | 2169 |
| HTRL (5-hydroxytryptamine (serotonin) receptor 1D) | 2161 |
| HTT (huntingtin) | 2170 |
| HTT (solute carrier family 6 (neurotransmitter transporter, serotonin), member 4) | 2397 |
| HuB219 (leptin receptor) | 2248 |
| HUG-BR1 (UDP glucuronosyltransferase 1 family, polypeptide A1) | 2483 |
| HUG-BR2 (UDP glucuronosyltransferase 1 family, polypeptide A4) | 2493 |
| Hum70t (heat shock 70kDa protein 1-like) | 2156 |
| HUMARA (androgen receptor) | 1183 |
| HUMPPARG (peroxisome proliferator-activated receptor gamma) | 2342 |
| humSULTC2 (sulfotransferase family, cytosolic, 1C, member 2) | 2435 |
| HUS (complement factor H) | 1244 |
| HUT2 (solute carrier family 14 (urea transporter), member 2) | 2402 |
| hUT-A6 (solute carrier family 14 (urea transporter), member 2) | 2402 |
| HYKPP (sodium channel, voltage-gated, type IV, alpha subunit) | 2387 |
| HYPP (sodium channel, voltage-gated, type IV, alpha subunit) | 2387 |
| HYSP1 (androgen receptor) | 1183 |
| I | |
| IBAT (solute carrier family 10 (sodium/bile acid cotransporter family), member 2) | 2400 |
| IBP1 (insulin-like growth factor 1 (somatomedin C)) | 2186 |
| ICAM1 (intercellular adhesion molecule 1) | 2175 |
| ICCD (sodium channel, voltage-gated, type V, alpha subunit) | 2388 |
| iCE (carboxylesterase 2 (intestine, liver)) | 1242 |
| ICIL-1RA (interleukin 1 receptor antagonist) | 2196 |
| ICOS (cytotoxic T-lymphocyte-associated protein 4) | 1273 |
| IDDM12 (cytotoxic T-lymphocyte-associated protein 4) | 1273 |
| IDDM22 (chemokine (C-C motif) receptor 5) | 1223 |
| I-FABP (fatty acid binding protein 2, intestinal) | 2053 |
| IFB (interferon, beta 1, fibroblast) | 2179 |
| IFC1 (solute carrier family 19 (folate transporter), member 1) | 2404 |
| IFF (interferon, beta 1, fibroblast) | 2179 |
| IFG (interferon, gamma) | 2181 |
| IFI (interferon, gamma) | 2181 |
| IFL (interferon, alpha 1) | 2178 |
| IFN (interferon, alpha 1) | 2178 |
| IFNA1 (interferon, alpha 1) | 2178 |
| IFNA13 (interferon, alpha 1) | 2178 |
| IFN-ALPHA (interferon, alpha 1) | 2178 |
| IFNA@ (interferon, alpha 1) | 2178 |
| IFNB (interferon, beta 1, fibroblast) | 2179 |
| IFNB1 (interferon, beta 1, fibroblast) | 2179 |
| IFNB2 (interleukin 6 (interferon, beta 2)) | 2204 |
| IFNG (interferon, gamma) | 2181 |
| IG (guanine nucleotide binding protein (G protein), beta polypeptide 3) | 2091 |
| IGEBF (Fc fragment of IgE, low affinity II, receptor for (CD23)) | 2054 |
| IGF1 (insulin-like growth factor 1 (somatomedin C)) | 2186 |
| IGF1A (insulin-like growth factor 1 (somatomedin C)) | 2186 |
| IGF2 (insulin-like growth factor 2 (somatomedin A)) | 2189 |
| IGF-IB (insulin-like growth factor 1 (somatomedin C)) | 2186 |
| IGFR2 (Fc fragment of IgG, low affinity IIa, receptor (CD32)) | 2055 |
| IGFR3 (Fc fragment of IgG, low affinity IIIa, receptor (CD16a)) | 2057 |
| IGHD1B (growth hormone 1) | 2085 |
| IIB1 (cytochrome P450, family 2, subfamily B, polypeptide 6) | 1356 |
| IKATP (potassium inwardly-rectifying channel, subfamily J, member 11) | 2232 |
| IL-1 (interleukin 1, beta) | 2190 |
| IL1B (interleukin 1, beta) | 2190 |
| IL1-BETA (interleukin 1, beta) | 2190 |
| IL1F2 (interleukin 1, beta) | 2190 |
| IL1F3 (interleukin 1 receptor antagonist) | 2196 |
| IL1RA (interleukin 1 receptor, type I) | 2196 |
| IL-1ra3 (interleukin 1 receptor antagonist) | 2196 |
| IL1RN (interleukin 1 receptor antagonist) | 2196 |
| IL2 (interleukin 2) | 2198 |
| IL-2 (interleukin 2) | 2198 |
| IL4 (interleukin 4) | 2201 |
| IL-4 (interleukin 4) | 2201 |
| IL6 (interleukin 6 (interferon, beta 2)) | 2204 |
| IL-6 (interleukin 6 (interferon, beta 2)) | 2204 |
| IL6R (interleukin 6 receptor) | 2210 |
| IL-6R-1 (interleukin 6 receptor) | 2210 |
| IL6RA (interleukin 6 receptor) | 2210 |
| IL-6R-alpha (interleukin 6 receptor) | 2210 |
| IL8R1 (interleukin 8 receptor, alpha) | 2211 |
| IL8R2 (interleukin 8 receptor, beta) | 2212 |
| IL8RA (interleukin 8 receptor, alpha) | 2211 |
| IL8RA (interleukin 8 receptor, beta) | 2212 |
| IL8RB (interleukin 8 receptor, beta) | 2212 |
| IL8RBA (interleukin 8 receptor, alpha) | 2211 |
| IL10 (interleukin 10) | 2213 |
| IL-10 (interleukin 10) | 2213 |
| IL10A (interleukin 10) | 2213 |
| IL12B (interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40)) | 2218 |
| IL17BR (interleukin 17 receptor B) | 2221 |
| IL17RB (interleukin 17 receptor B) | 2221 |
| IL17RH1 (interleukin 17 receptor B) | 2221 |
| IMAGE3455200 (vitamin K epoxide reductase complex, subunit 1) | 2520 |
| IMPCHASE (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase) | 1191 |
| IMPD (IMP (inosine monophosphate) dehydrogenase 1) | 2222 |
| IMPD1 (IMP (inosine monophosphate) dehydrogenase 1) | 2222 |
| IMPDH1 (IMP (inosine monophosphate) dehydrogenase 1) | 2222 |
| INCAM-100 (vascular cell adhesion molecule 1) | 2512 |
| INK4 (cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4)) | 1238 |
| INK4a (cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4)) | 1238 |
| INPP1 (inositol polyphosphate-1-phosphatase) | 2223 |
| INSIGF (insulin-like growth factor 2 (somatomedin A)) | 2189 |
| IP (prostaglandin I2 (prostacyclin) receptor (IP)) | 2363 |
| IPOB (superoxide dismutase 2, mitochondrial) | 2420 |
| IRAP (interleukin 1 receptor antagonist) | 2196 |
| IRF1 (interferon regulatory factor 1) | 2223 |
| IRF-1 (interferon regulatory factor 1) | 2223 |
| IRIS (breast cancer1, early onset) | 1204 |
| ISBT (solute carrier family 10 (sodium/bile acid cotransporter family), member 2) | 2400 |
| ISK (potassium voltage-gated channel, Isk-related family, member 1) | 2228 |
| ISOT (ubiquitin specific peptidase 5 (isopeptidase T)) | 2511 |
| IsoT (ubiquitin specific peptidase 5 (isopeptidase T)) | 2511 |
| IT15 (huntingtin) | 2170 |
| ITGA2 (integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)) | 2224 |
| ITGB3 (integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)) | 2225 |
| ITPA (inosine triphosphatase (nucleoside triphosphate pyrophosphatase)) | 2227 |
| ITPase (inosine triphosphatase (nucleoside triphosphate pyrophosphatase)) | 2227 |
| IVF (sodium channel, voltage-gated, type V, alpha subunit) | 2388 |
| J | |
| JLNS (potassium voltage-gated channel, Isk-related family, member 1) | 2228 |
| JLNS1 (potassium voltage-gated channel, KQT-like subfamily, member 1) | 2234 |
| JLNS2 (potassium voltage-gated channel, Isk-related family, member 1) | 2228 |
| JTK7 (c-abl oncogene 1, non-receptor tyrosine kinase) | 1025 |
| JTK12 (platelet-derived growth factor receptor, beta polypeptide) | 2330 |
| K | |
| K222 (TIMP metallopeptidase inhibitor 3) | 2450 |
| K222TA2 (TIMP metallopeptidase inhibitor 3) | 2450 |
| KA1 (glutamate receptor, ionotropic, kainate 4) | 2096 |
| KCNA8 (potassium voltage-gated channel, KQT-like subfamily, member 1) | 2234 |
| KCNA9 (potassium voltage-gated channel, KQT-like subfamily, member 1) | 2234 |
| KCNE1 (potassium voltage-gated channel, Isk-related family, member 1) | 2228 |
| KCNE2 (potassium voltage-gated channel, Isk-related family, member 2) | 2229 |
| KCNH2 (potassium voltage-gated channel, subfamily H (eag-related), member 2) | 2230 |
| KCNJ11 (potassium inwardly-rectifying channel, subfamily J, member 11) | 2232 |
| KCNQ1 (potassium voltage-gated channel, KQT-like subfamily, member 1) | 2234 |
| KD (androgen receptor) | 1183 |
| KDP (WNK lysine deficient protein kinase 1) | 2522 |
| KDR (kinase insert domain receptor (a type III receptor tyrosine kinase)) | 2236 |
| KIAA0238 (solute carrier family 23 (nucleobase transporters), member 2) | 2412 |
| KIAA0344 (WNK lysine deficient protein kinase 1) | 2522 |
| KIAA0403 (opioid receptor, mu 1) | 2321 |
| KIAA0525 (endoplasmic reticulum aminopeptidase 1) | 2022 |
| KIAA0578 (neurexin 1) | 2318 |
| KIAA0837 (acyl-CoA synthetase long-chain family member 6) | 1046 |
| KIAA0880 (solute carrier organic anion transporter family, member 2B1) | 2417 |
| KIAA1010 (ATP-binding cassette, sub-family C (CFTR/MRP), member 2) | 944 |
| KIAA1356 (sodium channel, voltage-gated, type III, alpha subunit) | 2387 |
| KIR6.2 (potassium inwardly-rectifying channel, subfamily J, member 11) | 2232 |
| Kir6.2 (potassium inwardly-rectifying channel, subfamily J, member 11) | 2232 |
| KI-RAS (v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) | 2239 |
| KIT (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog) | 2237 |
| KRAS (v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) | 2239 |
| KRAS1 (v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) | 2239 |
| KRAS2 (v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) | 2239 |
| K-RAS2A (v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) | 2239 |
| K-RAS2B (v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) | 2239 |
| K-RAS4A (v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) | 2239 |
| K-RAS4B (v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) | 2239 |
| Kv1.9 (potassium voltage-gated channel, KQT-like subfamily, member 1) | 2234 |
| Kv7.1 (potassium voltage-gated channel, KQT-like subfamily, member 1) | 2234 |
| Kv11.1 (potassium voltage-gated channel, subfamily H (eag-related), member 2) | 2230 |
| KVLQT1 (potassium voltage-gated channel, KQT-like subfamily, member 1) | 2234 |
| L | |
| L24178.1 (solute carrier family 6 (neurotransmitter transporter, dopamine), member 3) | 2395 |
| LAC (lactase) | 2243 |
| LACS (acyl-CoA synthetase long-chain family member 1) | 1042 |
| LACS 6 (acyl-CoA synthetase long-chain family member 6) | 1046 |
| LACS1 (acyl-CoA synthetase long-chain family member 1) | 1042 |
| LACS2 (acyl-CoA synthetase long-chain family member 1) | 1042 |
| LACS2 (acyl-CoA synthetase long-chain family member 6) | 1046 |
| LACS4 (acyl-CoA synthetase long-chain family member 4) | 1044 |
| LACS5 (acyl-CoA synthetase long-chain family member 6) | 1046 |
| LCA11 (IMP (inosine monophosphate) dehydrogenase 1) | 2222 |
| LCFS2 (mutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli)) | 2278 |
| LCK (lymphocyte-specific protein tyrosine kinase) | 2242 |
| LCT (lactase) | 2243 |
| LDLCQ2 (low density lipoprotein receptor) | 2243 |
| LDLCQ3 (3-hydroxy-3-methylglutaryl-Coenzyme A reductase) | 2145 |
| LDLCQ4 (apolipoprotein B (including Ag(x) antigen)) | 1118 |
| LDLCQ5 (apolipoprotein E) | 1121 |
| LDLR (low density lipoprotein receptor) | 2243 |
| LDS1A (transforming growth factor, beta receptor 1) | 2448 |
| LDS2A (transforming growth factor, beta receptor 1) | 2448 |
| LEM6 (peroxisome proliferator-activated receptor gamma, coactivator 1 alpha) | 2345 |
| LEP (leptin) | 2246 |
| LEPR (leptin receptor) | 2248 |
| L-FABP (fatty acid binding protein 1, liver) | 2052 |
| LFS1 (tumor protein p53) | 2468 |
| LGR1 (follicle stimulating hormone receptor) | 2074 |
| LIPC (lipase, hepatic) | 2249 |
| LIPH (lipase, hepatic) | 2249 |
| LMOR (opioid receptor, mu 1) | 2321 |
| LNCR2 (cholinergic receptor, nicotinic, alpha 5) | 1254 |
| LOG5 (arachidonate 5-lipoxygenase) | 1108 |
| LOL (lysyl oxidase-like 1) | 2250 |
| LOX5 (arachidonate 5-lipoxygenase) | 1108 |
| LOXL (lysyl oxidase-like 1) | 2250 |
| LOXL1 (lysyl oxidase-like 1) | 2250 |
| LPAAB (1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)) | 1082 |
| LPAAT-BETA (1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)) | 1082 |
| LPAAT-beta (1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)) | 1082 |
| LPG (apolipoprotein E) | 1121 |
| LPH (lactase) | 2243 |
| LPH1 (lactase) | 2243 |
| LPL (lipoprotein lipase) | 2251 |
| LPRS2 (parkinson protein 2, E3 ubiquitin protein ligase (parkin)) | 2325 |
| LQT (potassium voltage-gated channel, KQT-like subfamily, member 1) | 2234 |
| LQT1 (potassium voltage-gated channel, KQT-like subfamily, member 1) | 2234 |
| LQT2 (potassium voltage-gated channel, subfamily H (eag-related), member 2) | 2230 |
| LQT2/5 (potassium voltage-gated channel, Isk-related family, member 1) | 2228 |
| LQT3 (sodium channel, voltage-gated, type V, alpha subunit) | 2388 |
| LQT5 (potassium voltage-gated channel, Isk-related family, member 1) | 2228 |
| LQT5 (potassium voltage-gated channel, Isk-related family, member 2) | 2229 |
| LQT6 (potassium voltage-gated channel, Isk-related family, member 2) | 2229 |
| LRRK2 (leucine-rich repeat kinase 2) | 2253 |
| LSH (solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1) | 2401 |
| LSK (lymphocyte-specific protein tyrosine kinase) | 2242 |
| LST-1 (solute carrier organic anion transporter family, member 1B1) | 2414 |
| LST1 (solute carrier organic anion transporter family, member 1B1) | 2414 |
| LST3 (solute carrier organic anion transporter family, member 1B3) | 2416 |
| LST-3TM13 (solute carrier organic anion transporter family, member 1B3) | 2416 |
| LT (lymphotoxin alpha (TNF superfamily, member 1)) | 2254 |
| LTA (lymphotoxin alpha (TNF superfamily, member 1)) | 2254 |
| LTA4H (leukotriene A4 hydrolase) | 2256 |
| LTC4S (leukotriene C4 synthase) | 2256 |
| LUGP4 (UDP glucuronosyltransferase 1 family, polypeptide A9) | 2500 |
| LXG (arachidonate 5-lipoxygenase) | 1108 |
| Lymphokine (interleukin 2) | 2198 |
| M | |
| M1 (cholinergic receptor, muscarinic 1) | 1249 |
| M1R (cholinergic receptor, muscarinic 1) | 1249 |
| MAOA (monoamine oxidase A) | 2258 |
| MAOB (monoamine oxidase B) | 2260 |
| MAPK7 (mitogen-activated protein kinase 7) | 2261 |
| MAPT (microtubule-associated protein tau) | 2261 |
| MAPTL (microtubule-associated protein tau) | 2261 |
| MAR (interferon regulatory factor 1) | 2223 |
| MB67 (nuclear receptor subfamily 1, group I, member 3) | 2313 |
| MC1R (melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)) | 2266 |
| MDP1 (polymerase (DNA directed), gamma) | 2333 |
| MDR1 (ATP-binding cassette, sub-family B (MDR/TAP), member 1) | 824 |
| MEAI (multiple endocrine neoplasia I) | 2267 |
| MEH (epoxide hydrolase 1, microsomal (xenobiotic)) | 2020 |
| MEL-1A-R (melatonin receptor 1A) | 2288 |
| MEL-1B-R (melatonin receptor 1B) | 2289 |
| MEN1 (multiple endocrine neoplasia I) | 2267 |
| MEN2A (ret proto-oncogene) | 2377 |
| MEN2B (ret proto-oncogene) | 2377 |
| mENA (epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)) | 2015 |
| MERRF (mitochondrially encoded tRNA lysine) | 2284 |
| MET (met proto-oncogene (hepatocyte growth factor receptor) | 2269 |
| METS (5-methyltetrahydrofolate-homocysteine methyltransferase) | 2290 |
| MGC1198 (acyl-CoA oxidase 1, palmitoyl) | 1041 |
| MGC1571 (apolipoprotein E) | 1121 |
| MGC1632 (arachidonate 5-lipoxygenase) | 1108 |
| MGC1806 (aldehyde dehydrogenase 2 family (mitochondrial)) | 1103 |
| MGC2124 (regulator of G-protein signalling 4) | 2380 |
| MGC2237 (peroxisome proliferator-activated receptor alpha) | 2338 |
| MGC2318 (aldehyde dehydrogenase 1 family, member A1) | 1100 |
| MGC2452 (peroxisome proliferator-activated receptor alpha) | 2338 |
| MGC2483 (phosphatidylethanolamine N-methyltransferase) | 2331 |
| MGC2648 (Wingless-type MMTV integration site family, member 5B) | 2523 |
| MGC2694 (vitamin K epoxide reductase complex, subunit 1) | 2520 |
| MGC3339 (adducin 1 (alpha)) | 1050 |
| MGC3931 (peroxisome proliferator-activated receptor delta) | 2340 |
| MGC5057 (aminolevulinate dehydratase) | 1099 |
| MGC5105 (NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 4, 15kDa) | 2296 |
| MGC5163 (sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1) | 2431 |
| MGC5172 (mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli)) | 2272 |
| MGC5245 (interleukin 17 receptor B) | 2221 |
| MGC9284 (cAMP responsive element binding protein 1) | 1264 |
| MGC10317 (prostaglandin E synthase) | 2362 |
| MGC10398 (casein kinase 1, epsilon) | 1272 |
| MGC10406 (aldehyde dehydrogenase 3 family, member A1) | 1106 |
| MGC10430 (interleukin 1 receptor antagonist) | 2196 |
| MGC10442 (B lymphoid tyrosine kinase) | 1200 |
| MGC10601 (dopamine receptor D5) | 2006 |
| MGC14098 (glutathione synthetase) | 2102 |
| MGC14337 (melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)) | 2266 |
| MGC14458 (cyclin-dependent kinase 4) | 1234 |
| MGC16063 (signal transducer and activator of transcription 3 (acute-phase response factor)) | 2428 |
| MGC19588 (tumor necrosis factor receptor superfamily, member 1A) | 2464 |
| MGC20077 (superoxide dismutase 3, extracellular) | 2424 |
| MGC20210 (dystrobrevin binding protein 1) | 2008 |
| MGC22581 (aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4)) | 1098 |
| MGC23887 (Fc fragment of IgG, low affinity IIa, receptor (CD32)) | 2055 |
| MGC24086 (solute carrier family 22 (organic anion transporter), member 8) | 2410 |
| MGC24091 (solute carrier family 22 (organic anion transporter), member 7) | 2409 |
| MGC26382 (monoamine oxidase B) | 2260 |
| MGC26563 (glutathione S-transferase mu 1) | 2107 |
| MGC26566 (angiotensin I converting enzyme (peptidyl-dipeptidase A) 1) | 1027 |
| MGC26679 (prion protein) | 2347 |
| MGC27302 (prostaglandin E receptor 3 (subtype EP3)) | 2360 |
| MGC29860 (UDP glucuronosyltransferase 1 family, polypeptide A6) | 2495 |
| MGC30032 (Fc fragment of IgG, low affinity IIa, receptor (CD32)) | 2055 |
| MGC30125 (cholinergic receptor, muscarinic 1) | 1249 |
| MGC32628 (solute carrier family 22 (organic cation transporter), member 2) | 2406 |
| MGC33114 (potassium voltage-gated channel, Isk-related family, member 1) | 2228 |
| MGC33147 (leukotriene A4 hydrolase) | 2256 |
| MGC33735 (GNAS complex locus) | 2089 |
| MGC34313 (ATP-binding cassette, sub-family G (WHITE), member 1) | 985 |
| MGC34400 (flavin containing monooxygenase 3) | 2067 |
| MGC34459 (sulfotransferase family 1E, estrogen-preferring, member 1) | 2435 |
| MGC34546 (solute carrier family 22 (organic cation/ergothioneine transporter), member 4) | 2407 |
| MGC34632 (brain-derived neurotrophic factor) | 1198 |
| MGC40524 (solute carrier family 22 (organic cation/ergothioneine transporter), member 4) | 2407 |
| MGC44427 (adducin 1 (alpha)) | 1050 |
| MGC45202 (solute carrier family 22 (organic anion transporter), member 7) | 2409 |
| MGC45260 (solute carrier family 22 (organic anion transporter), member 6) | 2408 |
| MGC46203 (prostaglandin F receptor (FP)) | 2363 |
| MGC59692 (cyclin-dependent kinase 6) | 1236 |
| MGC60244 (regulator of G-protein signalling 4) | 2380 |
| MGC70609 (vascular endothelial growth factor A) | 2516 |
| MGC70799 (dihydropyrimidine dehydrogenase) | 1993 |
| MGC74427 (glutamate receptor, ionotropic, kainate 2) | 2095 |
| MGC74795 (platelet-derived growth factor receptor, alpha polypeptide) | 2328 |
| MGC79402 (interleukin 4) | 2201 |
| MGC87458 (fragile X mental retardation 1) | 2068 |
| MGC88246 (complement factor H) | 1244 |
| MGC88320 (cytochrome P450, family 2, subfamily C, polypeptide 9) | 1377 |
| MGC88736 (thymidylate synthetase) | 2479 |
| MGC96956 (interferon, beta 1, fibroblast) | 2179 |
| MGC97144 (nuclear receptor subfamily 1, group I, member 3) | 2313 |
| MGC97209 (nuclear receptor subfamily 1, group I, member 3) | 2313 |
| MGC99561 (vascular cell adhesion molecule 1) | 2512 |
| MGC99687 (glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding)) | 2097 |
| MGC102762 (excision repair cross-complementing rodent repair deficiency, complementation group 2) | 2029 |
| MGC102821 (ATP-binding cassette, sub-family G (WHITE), member 2) | 996 |
| MGC102830 (prostaglandin I2 (prostacyclin) receptor (IP)) | 2363 |
| MGC103790 (hemochromatosis) | 2126 |
| MGC104309 (cytochrome P450, family 19, subfamily A, polypeptide 1) | 1943 |
| MGC104327 (fibrinogen beta chain) | 2059 |
| MGC104991 (interleukin 6 receptor) | 2210 |
| MGC110988 (synuclein, alpha (non A4 component of amyloid precursor)) | 2418 |
| MGC111006 (FK506 binding protein 5) | 2061 |
| MGC111087 (major histocompatibility complex, class I, B) | 2131 |
| MGC111141 (haptoglobin) | 2152 |
| MGC111195 (cyclin-dependent kinase 1) | 1229 |
| MGC116903 (gamma-aminobutyric acid (GABA) A receptor, alpha 6) | 2078 |
| MGC117365 (carboxylesterase 1 (monocyte/macrophage serine esterase 1)) | 1241 |
| MGC117399 (apolipoprotein A-I) | 1115 |
| MGC117410 (deoxycytidine kinase) | 1987 |
| MGC117469 (sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3) | 2433 |
| MGC119566 (solute carrier family 14 (urea transporter), member 2) | 2402 |
| MGC119567 (solute carrier family 14 (urea transporter), member 2) | 2402 |
| MGC119994 (tryptophan hydroxylase 1) | 2474 |
| MGC120006 (cholinergic receptor, muscarinic 2) | 1250 |
| MGC120007 (cholinergic receptor, muscarinic 2) | 1250 |
| MGC120389 (cytochrome P450, family 2, subfamily D, polypeptide 6) | 1423 |
| MGC120390 (cytochrome P450, family 2, subfamily D, polypeptide 6) | 1423 |
| MGC120405 (fibrinogen beta chain) | 2059 |
| MGC120498 (prostaglandin F receptor (FP)) | 2363 |
| MGC125354 (solute carrier family 5 (iodide transporter), member 8) | 2393 |
| MGC126102 (matrix metalloproteinase 3 (stromelysin 1, progelatinase)) | 2276 |
| MGC126103 (matrix metalloproteinase 3 (stromelysin 1, progelatinase)) | 2276 |
| MGC126104 (matrix metalloproteinase 3 (stromelysin 1, progelatinase)) | 2276 |
| MGC126218 (excision repair cross-complementing rodent repair deficiency, complementation group 2) | 2029 |
| MGC126219 (excision repair cross-complementing rodent repair deficiency, complementation group 2) | 2029 |
| MGC126331 (spastic paraplegia 7 (pure and complicated autosomal recessive)) | 2425 |
| MGC126332 (spastic paraplegia 7 (pure and complicated autosomal recessive)) | 2425 |
| MGC126450 (interleukin 10) | 2213 |
| MGC126451 (interleukin 10) | 2213 |
| MGC126583 (prostaglandin E receptor 4 (subtype EP4)) | 2361 |
| MGC126680 (cytochrome P450, family 3, subfamily A, polypeptide 4) | 1622 |
| MGC126806 (v-raf murine sarcoma viral oncogene homolog B1) | 1203 |
| MGC126826 (cytochrome P450, family 7, subfamily A, polypeptide 1) | 1911 |
| MGC126836 (apolipoprotein A-V) | 1116 |
| MGC126838 (apolipoprotein A-V) | 1116 |
| MGC126858 (prostaglandin I2 (prostacyclin) synthase) | 2364 |
| MGC126860 (prostaglandin I2 (prostacyclin) synthase) | 2364 |
| MGC129579 (sialidase 2 (cytosolic sialidase)) | 2296 |
| MGC131921 (sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1) | 2431 |
| MGC131939 (glutathione S-transferase alpha 1) | 2104 |
| MGC132008 (dihydropyrimidine dehydrogenase) | 1993 |
| MGC133132 (fatty acid binding protein 2, intestinal) | 2053 |
| MGC133230 (potassium inwardly-rectifying channel, subfamily J, member 11) | 2232 |
| MGC133282 (solute carrier organic anion transporter family, member 1B1) | 2414 |
| MGC138140 (hydroxysteroid (17-beta) dehydrogenase 1 ) | 2156 |
| MGC138207 (interferon, alpha 1) | 2178 |
| MGC138242 (scavenger receptor class B, member 1) | 2384 |
| MGC138252 (solute carrier family 28 (sodium-coupled nucleoside transporter), member 2) | 2413 |
| MGC138284 (v-raf murine sarcoma viral oncogene homolog B1) | 1203 |
| MGC138292 (potassium voltage-gated channel, Isk-related family, member 2) | 2229 |
| MGC138389 (cytochrome P450, family 7, subfamily A, polypeptide 1) | 1911 |
| MGC138404 (v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian)) | 2026 |
| MGC138441 (calcium-sensing receptor) | 1211 |
| MGC138457 (steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)) | 2425 |
| MGC138502 (calcium channel, voltage-dependent, gamma-2 subunit) | 1210 |
| MGC138504 (calcium channel, voltage-dependent, gamma-2 subunit) | 1210 |
| MGC138505 (interferon, alpha 1) | 2178 |
| MGC138507 (interferon, alpha 1) | 2178 |
| MGC138549 (microtubule-associated protein tau) | 2261 |
| MGC138632 (deoxycytidine kinase) | 1987 |
| MGC138871 (tryptophan hydroxylase 2) | 2475 |
| MGC138872 (tryptophan hydroxylase 2) | 2475 |
| MGC141667 (follicle stimulating hormone receptor) | 2074 |
| MGC141668 (follicle stimulating hormone receptor) | 2074 |
| MGC141828 (prostaglandin E receptor 3 (subtype EP3)) | 2360 |
| MGC141829 (prostaglandin E receptor 3 (subtype EP3)) | 2360 |
| MGC142161 (phosphoinositide-3-kinase, catalytic, alpha polypeptide) | 2332 |
| MGC142163 (phosphoinositide-3-kinase, catalytic, alpha polypeptide) | 2332 |
| MGC142287 (sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2) | 2432 |
| MGC142289 (sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2) | 2432 |
| MGC149204 (dopamine receptor D3) | 2002 |
| MGC149205 (dopamine receptor D3) | 2002 |
| MGC149527 (major histocompatibility complex, class II, DQ alpha 1) | 2139 |
| MGC149819 (microsomal triglyceride transfer protein) | 2291 |
| MGC149820 (microsomal triglyceride transfer protein) | 2291 |
| MGC149895 (C-reactive protein, pentraxin-related) | 1267 |
| MGC150353 (apolipoprotein C-III) | 1119 |
| MGC150433 (nuclear receptor subfamily 1, group I, member 3) | 2313 |
| MGC163204 (arachidonate 5-lipoxygenase) | 1108 |
| MGC164864 (ATP-binding cassette, sub-family A (ABC1), member 1) | 812 |
| MGC165011 (ATP-binding cassette, sub-family A (ABC1), member 1) | 812 |
| MGF (insulin-like growth factor 1 (somatomedin C)) | 2186 |
| mGlu3 (glutamate receptor, metabotropic 3) | 2098 |
| MGMT (O-6-methylguanine-DNA methyltransferase) | 2270 |
| MGST1L1 (prostaglandin E synthase) | 2362 |
| MGST1-L1 (prostaglandin E synthase) | 2362 |
| MGST-IV (prostaglandin E synthase) | 2362 |
| MHS (ryanodine receptor 1 (skeletal)) | 2382 |
| MHS1 (ryanodine receptor 1 (skeletal)) | 2382 |
| MLM (cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4)) | 1238 |
| MLN 19 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)) | 2023 |
| MLP1 (ATP-binding cassette, sub-family C (CFTR/MRP), member 6) | 971 |
| MinK (potassium voltage-gated channel, Isk-related family, member 1) | 2228 |
| MiRP1 (potassium voltage-gated channel, Isk-related family, member 2) | 2229 |
| MIRP1 (potassium voltage-gated channel, Isk-related family, member 2) | 2229 |
| MK (ATPase, Cu++ transporting, alpha polypeptide) | 1192 |
| MLH1 (mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli)) | 2272 |
| MLP2 (ATP-binding cassette, sub-family C (CFTR/MRP), member 3) | 963 |
| MLTF2 (upstream transcription factor 2, c-fos interacting) | 2510 |
| MM02 (matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)) | 2274 |
| MMP2 (matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)) | 2274 |
| MMP3 (matrix metalloproteinase 3 (stromelysin 1, progelatinase)) | 2276 |
| MMP-3 (matrix metalloproteinase 3 (stromelysin 1, progelatinase)) | 2276 |
| MMPII (matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)) | 2274 |
| MNK (ATPase, Cu++ transporting, alpha polypeptide) | 1192 |
| MNSOD (superoxide dismutase 2, mitochondrial) | 2420 |
| MOATB (ATP-binding cassette, sub-family C (CFTR/MRP), member 4) | 965 |
| MOATE (ATP-binding cassette, sub-family C (CFTR/MRP), member 6) | 971 |
| MOAT-B (ATP-binding cassette, sub-family C (CFTR/MRP), member 4) | 965 |
| MOAT-D (ATP-binding cassette, sub-family C (CFTR/MRP), member 3) | 963 |
| MODY (hepatocyte nuclear factor 4, alpha) | 2147 |
| MODY1 (hepatocyte nuclear factor 4, alpha) | 2147 |
| MODY11 (B lymphoid tyrosine kinase) | 1200 |
| MONA (matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)) | 2274 |
| MOR (opioid receptor, mu 1) | 2321 |
| MOR1 (opioid receptor, mu 1) | 2321 |
| MOX1 (NADPH oxidase 1) | 2302 |
| MP-12/MP-20 (cytochrome P450, family 2, subfamily C, polypeptide 8) | 1368 |
| MPGES (prostaglandin E synthase) | 2362 |
| mPGES-1 (prostaglandin E synthase) | 2362 |
| M-PST (sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3) | 2433 |
| MRP (ATP-binding cassette, sub-family C (CFTR/MRP), member 1) | 930 |
| MRP1 (ATP-binding cassette, sub-family C (CFTR/MRP), member 1) | 930 |
| MRP2 (ATP-binding cassette, sub-family C (CFTR/MRP), member 2) | 944 |
| MRP3 (ATP-binding cassette, sub-family C (CFTR/MRP), member 3) | 963 |
| MRP4 (ATP-binding cassette, sub-family C (CFTR/MRP), member 4) | 965 |
| MRP6 (ATP-binding cassette, sub-family C (CFTR/MRP), member 6) | 971 |
| MRP7 (cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)) | 1245 |
| MRP8 (ATP-binding cassette, sub-family C (CFTR/MRP), member 8) | 979 |
| MRT6 (glutamate receptor, ionotropic, kainate 2) | 2095 |
| MRX (ATP-binding cassette, sub-family G (WHITE), member 2) | 996 |
| MRX63 (acyl-CoA synthetase long-chain family member 4) | 1044 |
| MRX68 (acyl-CoA synthetase long-chain family member 4) | 1044 |
| MRX94 (glutamate receptor, ionotrophic, AMPA 3) | 2093 |
| MS (5-methyltetrahydrofolate-homocysteine methyltransferase) | 2290 |
| MSH2 (mutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli)) | 2278 |
| MSH-R (melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)) | 2266 |
| MST134 (vitamin K epoxide reductase complex, subunit 1) | 2520 |
| MST576 (vitamin K epoxide reductase complex, subunit 1) | 2520 |
| MSTD (microtubule-associated protein tau) | 2261 |
| MT1 (melatonin receptor 1A) | 2288 |
| MT2 (melatonin receptor 1B) | 2289 |
| MT-ATP6 (mitochondrially encoded ATP synthase 6) | 2279 |
| MT-COI (mitochondrially encoded cytochrome c oxidase I) | 2280 |
| MT-ND1 (mitochondrially encoded NADH dehydrogenase 1) | 2281 |
| MT-ND4 (mitochondrially encoded NADH dehydrogenase 4) | 2282 |
| MT-ND6 (mitochondrially encoded NADH dehydrogenase 6) | 2283 |
| MT-RNR1 (mitochondrially encoded 12S RNA) | 2283 |
| MT-TK (mitochondrially encoded tRNA lysine) | 2284 |
| MT-TL1 (mitochondrially encoded tRNA leucine 1 (UUA/G)) | 2285 |
| MTATP6 (mitochondrially encoded ATP synthase 6) | 2279 |
| MTBT1 (microtubule-associated protein tau) | 2261 |
| MTBT2 (microtubule-associated protein tau) | 2261 |
| MTC1 (ret proto-oncogene) | 2377 |
| MTCO1 (mitochondrially encoded cytochrome c oxidase I) | 2280 |
| MTHFR (5,10-methylenetetrahydrofolate reductase (NADPH)) | 2285 |
| MTND1 (mitochondrially encoded NADH dehydrogenase 1) | 2281 |
| MTND4 (mitochondrially encoded NADH dehydrogenase 4) | 2282 |
| MTND6 (mitochondrially encoded NADH dehydrogenase 6) | 2283 |
| MTNR1A (melatonin receptor 1A) | 2288 |
| MTNR1B (melatonin receptor 1B) | 2289 |
| MTP (microsomal triglyceride transfer protein) | 2291 |
| MTR (5-methyltetrahydrofolate-homocysteine methyltransferase) | 2290 |
| MTRNR1 (mitochondrially encoded 12S RNA) | 2283 |
| MTS1 (cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4)) | 1238 |
| MTTK (mitochondrially encoded tRNA lysine) | 2284 |
| MTTL1 (mitochondrially encoded tRNA leucine 1 (UUA/G)) | 2285 |
| MTTP (microsomal triglyceride transfer protein) | 2291 |
| MU (glutathione S-transferase mu 1) | 2107 |
| MU-1 (glutathione S-transferase mu 1) | 2107 |
| MVCD1 (vascular endothelial growth factor A) | 2516 |
| MVCD3 (angiotensin I converting enzyme (peptidyl-dipeptidase A) 1) | 1027 |
| MVCD4 (interleukin 1 receptor antagonist) | 2196 |
| MVCD5 (paraoxonase 1) | 2335 |
| MVCD6 (superoxide dismutase 2, mitochondrial) | 2420 |
| MVCD7 (hemochromatosis) | 2126 |
| MXR (ATP-binding cassette, sub-family G (WHITE), member 2) | 996 |
| MXR1 (ATP-binding cassette, sub-family G (WHITE), member 2) | 996 |
| My031 (dystrobrevin binding protein 1) | 2008 |
| N | |
| Na(v)1.2 (sodium channel, voltage-gated, type II, alpha subunit) | 2386 |
| Na(V)1.4 (sodium channel, voltage-gated, type IV, alpha subunit) | 2387 |
| NAC1 (sodium channel, voltage-gated, type I, alpha subunit) | 2385 |
| NAC1A (sodium channel, voltage-gated, type IV, alpha subunit) | 2387 |
| NAC2 (sodium channel, voltage-gated, type II, alpha subunit) | 2386 |
| NAC3 (sodium channel, voltage-gated, type III, alpha subunit) | 2387 |
| N-ACHE (acetylcholinesterase (Yt blood group) | 1036 |
| NACHR (cholinergic receptor, nicotinic, alpha 4) | 1253 |
| NACHRA4 (cholinergic receptor, nicotinic, alpha 4) | 1253 |
| nAChRB2 (cholinergic receptor, nicotinic, beta 2 (neuronal)) | 1255 |
| NACP (synuclein, alpha (non A4 component of amyloid precursor)) | 2418 |
| NACRA4 (cholinergic receptor, nicotinic, alpha 4) | 1253 |
| NAD1 (mitochondrially encoded NADH dehydrogenase 1) | 2281 |
| NAD4 (mitochondrially encoded NADH dehydrogenase 4) | 2282 |
| NAD6 (mitochondrially encoded NADH dehydrogenase 6) | 2283 |
| NAT1 (solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2) | 2394 |
| NAT2 (N-acetyltransferase 2 (arylamine N-acetyltransferase)) | 2293 |
| Nav1.1 (sodium channel, voltage-gated, type I, alpha subunit) | 2385 |
| Nav1.2 (sodium channel, voltage-gated, type II, alpha subunit) | 2386 |
| Nav1.3 (sodium channel, voltage-gated, type III, alpha subunit) | 2387 |
| Nav1.4 (sodium channel, voltage-gated, type IV, alpha subunit) | 2387 |
| Nav1.5 (sodium channel, voltage-gated, type V, alpha subunit) | 2388 |
| Nav1.7 (sodium channel, voltage-gated, type IX, alpha subunit) | 2390 |
| NBTL1 (solute carrier family 23 (nucleobase transporters), member 2) | 2412 |
| NCCT (solute carrier family 12 (sodium/chloride transporters), member 3) | 2402 |
| ND1 (mitochondrially encoded NADH dehydrogenase 1) | 2281 |
| ND4 (mitochondrially encoded NADH dehydrogenase 4) | 2282 |
| ND6 (mitochondrially encoded NADH dehydrogenase 6) | 2283 |
| NDUFB4 (NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 4, 15kDa) | 2296 |
| NENA (sodium channel, voltage-gated, type IX, alpha subunit) | 2390 |
| NE-NA (sodium channel, voltage-gated, type IX, alpha subunit) | 2390 |
| NESP (GNAS complex locus) | 2089 |
| NET (solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2) | 2394 |
| NET1 (solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2) | 2394 |
| NEU (v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)) | 2023 |
| NEU2 (sialidase 2 (cytosolic sialidase)) | 2296 |
| NF-25 (cytochrome P450, family 3, subfamily A, polypeptide 4) | 1622 |
| NGL (v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)) | 2023 |
| NIS (solute carrier family 5 (sodium iodide symporter), member 5) | 2392 |
| NK2R (tachykinin receptor 2) | 2437 |
| NK-2R (tachykinin receptor 2) | 2437 |
| NKNAR (tachykinin receptor 2) | 2437 |
| NKSF (interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40)) | 2218 |
| NKSF2 (interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40)) | 2218 |
| NLT (solute carrier family 22 (organic anion transporter), member 7) | 2409 |
| NM_000927.1 (ATP-binding cassette, sub-family B (MDR/TAP), member 1) | 824 |
| NM_003056.1 (solute carrier family 19 (folate transporter), member 1) | 2404 |
| NM_003059.1 (solute carrier family 22 (organic cation/ergothioneine transporter), member 4) | 2407 |
| NM_021082.1 (solute carrier family 15 (H+/peptide transporter), member 2) | 2404 |
| NMDARA1 (glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding)) | 2097 |
| NMOR1 (NAD(P)H dehydrogenase, quinone 1) | 2306 |
| NMORI (NAD(P)H dehydrogenase, quinone 1) | 2306 |
| NNMT (nicotinamide N-methyltransferase) | 2296 |
| NOH1 (NADPH oxidase 1) | 2302 |
| NOH-1 (NADPH oxidase 1) | 2302 |
| NOS III (nitric oxide synthase 3 (endothelial cell)) | 2298 |
| NOS3 (nitric oxide synthase 3 (endothelial cell)) | 2298 |
| NOTCH3 (notch 3) | 2301 |
| NOX1 (NADPH oxidase 1) | 2302 |
| NPC (Niemann-Pick disease, type C1) | 2303 |
| NPC1 (Niemann-Pick disease, type C1) | 2303 |
| NPPA (natriuretic peptide precursor A) | 2304 |
| NPY (neuropeptide Y) | 2305 |
| NQO1 (NAD(P)H dehydrogenase, quinone 1) | 2306 |
| NR1C1 (peroxisome proliferator-activated receptor alpha) | 2338 |
| NR1C2 (peroxisome proliferator-activated receptor delta) | 2340 |
| NR1C3 (peroxisome proliferator-activated receptor gamma) | 2342 |
| NR1I2 (nuclear receptor subfamily 1, group I, member 2) | 2309 |
| NR1I3 (nuclear receptor subfamily 1, group I, member 3) | 2313 |
| NR2A1 (hepatocyte nuclear factor 4, alpha) | 2147 |
| NR2A21 (hepatocyte nuclear factor 4, alpha) | 2147 |
| NR3A1 (estrogen receptor 1) | 2034 |
| NR3A2 (estrogen receptor 2 (ER beta)) | 2042 |
| NR3C1 (nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)) | 2314 |
| NR3C4 (androgen receptor) | 1183 |
| NR111 (vitamin D (1,25- dihydroxyvitamin D3) receptor) | 2513 |
| NRAMP (solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1) | 2401 |
| NRAMP1 (solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1) | 2401 |
| NRXN1 (neurexin 1) | 2318 |
| NS3 (v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) | 2239 |
| NSHPT (calcium-sensing receptor) | 1211 |
| NTCP (solute carrier family 10 (sodium/bile acid cotransporter family), member 1) | 2399 |
| NTCP2 (solute carrier family 10 (sodium/bile acid cotransporter family), member 2) | 2400 |
| NTPH (tryptophan hydroxylase 2) | 2475 |
| NTRK2 (neurotrophic tyrosine kinase, receptor, type 2) | 2318 |
| NUC1 (peroxisome proliferator-activated receptor delta) | 2340 |
| NUCI (peroxisome proliferator-activated receptor delta) | 2340 |
| NUCII (peroxisome proliferator-activated receptor delta) | 2340 |
| NX1A (neurexin 1) | 2318 |
| O | |
| OASL (2′-5′-oligoadenylate synthetase-like) | 2321 |
| OAT1 (solute carrier family 22 (organic anion transporter), member 6) | 2408 |
| OAT2 (solute carrier family 22 (organic anion transporter), member 7) | 2409 |
| OAT3 (solute carrier family 22 (organic anion transporter), member 8) | 2410 |
| OATP (solute carrier organic anion transporter family, member 1A2) | 2413 |
| OATP1 (solute carrier organic anion transporter family, member 1C1) | 2416 |
| OATP1A2 (solute carrier organic anion transporter family, member 1A2) | 2413 |
| OATP1B1 (solute carrier organic anion transporter family, member 1B1) | 2414 |
| OATP1B3 (solute carrier organic anion transporter family, member 1B3) | 2416 |
| OATP1C1 (solute carrier organic anion transporter family, member 1C1) | 2416 |
| OATP2 (solute carrier organic anion transporter family, member 1B1) | 2414 |
| OATP2B1 (solute carrier organic anion transporter family, member 2B1) | 2417 |
| OATP8 (solute carrier organic anion transporter family, member 1B3) | 2416 |
| OATP-A (solute carrier organic anion transporter family, member 1A2) | 2413 |
| OATPB (solute carrier organic anion transporter family, member 2B1) | 2417 |
| OATP-B (solute carrier organic anion transporter family, member 2B1) | 2417 |
| OATPC (solute carrier organic anion transporter family, member 1B1) | 2414 |
| OATP-C (solute carrier organic anion transporter family, member 1B1) | 2414 |
| OATP-F (solute carrier organic anion transporter family, member 1C1) | 2416 |
| OATPRP5 (solute carrier organic anion transporter family, member 1C1) | 2416 |
| OB (leptin) | 2246 |
| OBR (leptin receptor) | 2248 |
| OBRB (leptin receptor) | 2248 |
| OBS (leptin) | 2246 |
| OCD1 (solute carrier family 6 (neurotransmitter transporter, serotonin), member 4) | 2397 |
| OCT1 (solute carrier family 22 (organic cation transporter), member 1) | 2406 |
| oct1_cds (solute carrier family 22 (organic cation transporter), member 1) | 2406 |
| OCT2 (solute carrier family 22 (organic cation transporter), member 2) | 2406 |
| OCT6 (solute carrier family 22 (organic cation/carnitine transporter), member 16) | 2411 |
| OCTN1 (solute carrier family 22 (organic cation/ergothioneine transporter), member 4) | 2407 |
| ODG1 (follicle stimulating hormone receptor) | 2074 |
| OI4 (collagen, type I, alpha 1) | 1259 |
| OK/SW-cl.29 (thymidylate synthetase) | 2479 |
| OK/SW-cl.86 (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase) | 1191 |
| OK/SW-cl.88 (sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1) | 2431 |
| OKB1 (solute carrier family 22 (organic cation/carnitine transporter), member 16) | 2411 |
| ONR1 (nuclear receptor subfamily 1, group I, member 2) | 2309 |
| OPRM (opioid receptor, mu 1) | 2321 |
| OPRM1 (opioid receptor, mu 1) | 2321 |
| ORM (orosomucoid 1) | 2323 |
| ORM1 (orosomucoid 1) | 2323 |
| ORW2 (activin A receptor, type II-like 1) | 1046 |
| OSRC (retinoblastoma 1) | 2374 |
| P | |
| P1-450 (cytochrome P450, family 1, subfamily A, polypeptide 1) | 1275 |
| P2RY1 (purinergic receptor P2Y, G-protein coupled, 1) | 2324 |
| P2RY12 (purinergic receptor P2Y, G-protein coupled, 12) | 2324 |
| P2T(AC)(purinergic receptor P2Y, G-protein coupled, 12) | 2324 |
| P2Y(AC)(purinergic receptor P2Y, G-protein coupled, 12) | 2324 |
| P2Y(ADP)(purinergic receptor P2Y, G-protein coupled, 12) | 2324 |
| P2Y(cyc)(purinergic receptor P2Y, G-protein coupled, 12) | 2324 |
| P2Y1 (purinergic receptor P2Y, G-protein coupled, 1) | 2324 |
| P2Y12 (purinergic receptor P2Y, G-protein coupled, 12) | 2324 |
| P3-450 (cytochrome P450, family 1, subfamily A, polypeptide 2) | 1297 |
| P3.58 (intercellular adhesion molecule 1) | 2175 |
| P5-1 (HLA complex P5) | 2125 |
| P14 (cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4)) | 1238 |
| P14ARF (cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4)) | 1238 |
| P16 (cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4)) | 1238 |
| P16INK4 (cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4)) | 1238 |
| P16INK4a (cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4)) | 1238 |
| P19 (cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4)) | 1238 |
| P19Arf (cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4)) | 1238 |
| P28 (glutathione S-transferase omega 1) | 2111 |
| p33(CDK2)(cyclin-dependent kinase 2) | 1232 |
| P34CDC2 (cyclin-dependent kinase 1) | 1229 |
| p53 (tumor protein p53) | 2468 |
| P54 (FK506 binding protein 5) | 2061 |
| p55 (tumor necrosis factor receptor superfamily, member 1A) | 2464 |
| p55-R (tumor necrosis factor receptor superfamily, member 1A) | 2464 |
| p56lck (lymphocyte-specific protein tyrosine kinase) | 2242 |
| p59OASL (2′-5′-oligoadenylate synthetase-like) | 2321 |
| p60 (tumor necrosis factor receptor superfamily, member 1A) | 2464 |
| p75 (tumor necrosis factor receptor subfamily, member 1B) | 2465 |
| p75TNFR (tumor necrosis factor receptor subfamily, member 1B) | 2465 |
| p105-Rb (retinoblastoma 1) | 2374 |
| p110-alpha (phosphoinositide-3-kinase, catalytic, alpha polypeptide) | 2332 |
| P130Cas (breast cancer antiestrogen resistance 1) | 1194 |
| p150 (c-abl oncogene 1, non-receptor tyrosine kinase) | 1025 |
| p180erbB4 (v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian)) | 2026 |
| P450 MP-4 (cytochrome P450, family 2, subfamily C, polypeptide 9) | 1377 |
| P450 PB-1 (cytochrome P450, family 2, subfamily C, polypeptide 9) | 1377 |
| P450 (cytochrome P450, family 2, subfamily B, polypeptide 6) | 1356 |
| P450(PA)(cytochrome P450, family 1, subfamily A, polypeptide 2) | 1297 |
| P4501B1 (cytochrome P450, family 1, subfamily B, polypeptide 1) | 1335 |
| P450-6B/29C (cytochrome P450, family 2, subfamily C, polypeptide 18) | 1401 |
| P-450AROM (cytochrome P450, family 19, subfamily A, polypeptide 1) | 1943 |
| P-450HP (cytochrome P450, family 4, subfamily B, polypeptide 1) | 1902 |
| P450-C (cytochrome P450, family 1, subfamily A, polypeptide 1) | 1275 |
| P450aldo (cytochrome P450, family 11, subfamily B, polypeptide 2) | 1932 |
| P450C2A (cytochrome P450, family 2, subfamily A, polypeptide 6) | 1347 |
| P450C2C (cytochrome P450, family 2, subfamily C, polypeptide 19) | 1404 |
| P450C2D (cytochrome P450, family 2, subfamily D, polypeptide 6) | 1423 |
| P450C2E (cytochrome P450, family 2, subfamily E, polypeptide 1) | 1589 |
| P450C3 (cytochrome P450, family 3, subfamily A, polypeptide 4) | 1622 |
| P450C18 (cytochrome P450, family 11, subfamily B, polypeptide 2) | 1932 |
| P-450C18 (cytochrome P450, family 11, subfamily B, polypeptide 2) | 1932 |
| P450DB1 (cytochrome P450, family 2, subfamily D, polypeptide 6) | 1423 |
| P450-DB1 (cytochrome P450, family 2, subfamily D, polypeptide 6) | 1423 |
| P450DX.3 (cytochrome P450, family 1, subfamily A, polypeptide 1) | 1275 |
| P450IIC17 (cytochrome P450, family 2, subfamily C, polypeptide 18) | 1401 |
| P450IIC19 (cytochrome P450, family 2, subfamily C, polypeptide 19) | 1404 |
| P450IIC9 (cytochrome P450, family 2, subfamily C, polypeptide 9) | 1377 |
| P450-J (cytochrome P450, family 2, subfamily E, polypeptide 1) | 1589 |
| P450PB (cytochrome P450, family 2, subfamily A, polypeptide 6) | 1347 |
| P450PCN1 (cytochrome P450, family 3, subfamily A, polypeptide 4) | 1622 |
| P450PCN3 (cytochrome P450, family 3, subfamily A, polypeptide 5) | 1901 |
| PAHT (solute carrier family 22 (organic anion transporter), member 6) | 2408 |
| PALMCOX (acyl-CoA oxidase 1, palmitoyl) | 1041 |
| PAR (nuclear receptor subfamily 1, group I, member 2) | 2309 |
| PAR1 (nuclear receptor subfamily 1, group I, member 2) | 2309 |
| PAR2 (nuclear receptor subfamily 1, group I, member 2) | 2309 |
| PARK1 (synuclein, alpha (non A4 component of amyloid precursor)) | 2418 |
| PARK4 (synuclein, alpha (non A4 component of amyloid precursor)) | 2418 |
| PARK2 (parkinson protein 2, E3 ubiquitin protein ligase (parkin)) | 2325 |
| PARK8 (leucine-rich repeat kinase 2) | 2253 |
| PARq (nuclear receptor subfamily 1, group I, member 2) | 2309 |
| PBAM (solute carrier family 10 (sodium/bile acid cotransporter family), member 2) | 2400 |
| PBGS (aminolevulinate dehydratase) | 1099 |
| PBT (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog) | 2237 |
| PC (protein C (inactivator of coagulation factors Va and VIIIa)) | 2352 |
| PCAR1 (calcium-sensing receptor) | 1211 |
| PCCF (coagulation factor V (proaccelerin, labile factor)) | 2049 |
| PCE-1 (carboxylesterase 1 (monocyte/macrophage serine esterase 1)) | 1241 |
| PCE-2 (carboxylesterase 2 (intestine, liver)) | 1242 |
| PCN3 (cytochrome P450, family 3, subfamily A, polypeptide 5) | 1901 |
| PCOX1 (prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)) | 2365 |
| PD1 (synuclein, alpha (non A4 component of amyloid precursor)) | 2418 |
| PDE1C (phosphodiesterase 1C, calmodulin-dependent 70kDa) | 2327 |
| PDE5 (phosphodiesterase 5A, cGMP-specific) | 2327 |
| PDE5A (phosphodiesterase 5A, cGMP-specific) | 2327 |
| PDE5A1 (phosphodiesterase 5A, cGMP-specific) | 2327 |
| PDGFR (platelet-derived growth factor receptor, beta polypeptide) | 2330 |
| PDGFR1 (platelet-derived growth factor receptor, beta polypeptide) | 2330 |
| PDGFR2 (platelet-derived growth factor receptor, alpha polypeptide) | 2328 |
| PDGFRA (platelet-derived growth factor receptor, alpha polypeptide) | 2328 |
| PDGFRB (platelet-derived growth factor receptor, beta polypeptide) | 2330 |
| PDJ (parkinson protein 2, E3 ubiquitin protein ligase (parkin)) | 2325 |
| PEAMT (phosphatidylethanolamine N-methyltransferase) | 2331 |
| PEMPT (phosphatidylethanolamine N-methyltransferase) | 2331 |
| PEMT (phosphatidylethanolamine N-methyltransferase) | 2331 |
| PEMT2 (phosphatidylethanolamine N-methyltransferase) | 2331 |
| PEO (polymerase (DNA directed), gamma) | 2333 |
| PEPT1 (solute carrier family 15 (oligopeptide transporter), member 1) | 2403 |
| PEPT2 (solute carrier family 15 (H+/peptide transporter), member 2) | 2404 |
| PF2R (prostaglandin F receptor (FP)) | 2363 |
| PFHB1 (sodium channel, voltage-gated, type V, alpha subunit) | 2388 |
| PFIC-2 (ATP-binding cassette, sub-family B (MDR/TAP), member 11) | 928 |
| PFIC2 (ATP-binding cassette, sub-family B (MDR/TAP), member 11) | 928 |
| PGC-1(alpha)(peroxisome proliferator-activated receptor gamma, coactivator 1 alpha) | 2345 |
| PGC1 (peroxisome proliferator-activated receptor gamma, coactivator 1 alpha) | 2345 |
| PGC1A (peroxisome proliferator-activated receptor gamma, coactivator 1 alpha) | 2345 |
| PGC-1v (peroxisome proliferator-activated receptor gamma, coactivator 1 alpha) | 2345 |
| PGES (prostaglandin E synthase) | 2362 |
| PGG/HS (prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)) | 2365 |
| PGG/HS (prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)) | 2367 |
| PGHS-1 (prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)) | 2365 |
| PGHS1 (prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)) | 2365 |
| PGHS-2 (prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)) | 2367 |
| PGIS (prostaglandin I2 (prostacyclin) synthase) | 2364 |
| PGN (spastic paraplegia 7 (pure and complicated autosomal recessive)) | 2425 |
| P-GP (ATP-binding cassette, sub-family B (MDR/TAP), member 1)) | 824 |
| P-gp (ATP-binding cassette, sub-family B (MDR/TAP), member 1)) | 824 |
| PGY1 (ATP-binding cassette, sub-family B (MDR/TAP), member 1)) | 824 |
| PGY4 (ATP-binding cassette, sub-family B (MDR/TAP), member 11)) | 928 |
| PH1 (alanine-glyoxylate aminotransferase) | 1092 |
| PHA1 (sodium channel, nonvoltage-gated 1, gamma) | 2391 |
| PHA2C (WNK lysine deficient protein kinase 1) | 2522 |
| PHHI (ATP-binding cassette, sub-family C (CFTR/MRP), member 8)) | 979 |
| PHHI (potassium inwardly-rectifying channel, subfamily J, member 11) | 2232 |
| PHL (breakpoint cluster region) | 1196 |
| PHP1A (GNAS complex locus) | 2089 |
| PHP1B (GNAS complex locus) | 2089 |
| PHS1 (prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)) | 2365 |
| PHS-2 (prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)) | 2367 |
| PI (glutathione S-transferase pi 1) | 2113 |
| PI3K (phosphoinositide-3-kinase, catalytic, alpha polypeptide) | 2332 |
| PIG12 (prostaglandin E synthase) | 2362 |
| PIG61 (epidermal growth factor receptor) | 2015 |
| PIK3CA (phosphoinositide-3-kinase, catalytic, alpha polypeptide) | 2332 |
| PILSAP (endoplasmic reticulum aminopeptidase 1) | 2022 |
| PILS-AP (endoplasmic reticulum aminopeptidase 1) | 2022 |
| PLSTIRE (cyclin-dependent kinase 6) | 1236 |
| PN1 (sodium channel, voltage-gated, type IX, alpha subunit) | 2390 |
| PN2 (amyloid beta (A4) precursor protein) | 1161 |
| PNAT (N-acetyltransferase 2 (arylamine N-acetyltransferase)) | 2293 |
| PNCA2 (breast cancer 2, early onset) | 1208 |
| PNCA4 (breast cancer1, early onset) | 1204 |
| PND (natriuretic peptide precursor A) | 2304 |
| PNMT (phosphatidylethanolamine N-methyltransferase) | 2331 |
| POADS (dihydroorotate dehydrogenase) | 1989 |
| POF (fragile X mental retardation 1) | 2068 |
| POF1 (fragile X mental retardation 1) | 2068 |
| POH (GNAS complex locus) | 2089 |
| POLG (polymerase (DNA directed), gamma)) | 2333 |
| POLG1 (polymerase (DNA directed), gamma)) | 2333 |
| POLGA (polymerase (DNA directed), gamma)) | 2333 |
| PON (paraoxonase 1) | 2335 |
| PON1 (paraoxonase 1) | 2335 |
| pp58lck (lymphocyte-specific protein tyrosine kinase) | 2242 |
| PP102 (prostaglandin E synthase) | 2362 |
| pp110 (retinoblastoma 1) | 2374 |
| PP1294 (prostaglandin E synthase) | 2362 |
| pp9974 (insulin-like growth factor 2 (somatomedin A)) | 2189 |
| PPAR (peroxisome proliferator-activated receptor alpha) | 2338 |
| PPARA (peroxisome proliferator-activated receptor alpha) | 2338 |
| PPARB (peroxisome proliferator-activated receptor delta) | 2340 |
| PPARD (peroxisome proliferator-activated receptor delta) | 2340 |
| PPARG (peroxisome proliferator-activated receptor gamma) | 2342 |
| PPARG1 (peroxisome proliferator-activated receptor gamma) | 2342 |
| PPARG2 (peroxisome proliferator-activated receptor gamma) | 2342 |
| PPARgamma (peroxisome proliferator-activated receptor gamma) | 2342 |
| PPARGC1 (peroxisome proliferator-activated receptor gamma, coactivator 1 alpha) | 2345 |
| PPARGC1A (peroxisome proliferator-activated receptor gamma, coactivator 1 alpha) | 2345 |
| PPET1 (endothelin 1) | 2011 |
| PPH1 (bone morphogenetic protein receptor, type II (serine/threonine kinase)) | 1202 |
| PPIase (FK506 binding protein 5) | 2061 |
| PPND (microtubule-associated protein tau) | 2261 |
| P-PST (sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1) | 2431 |
| P-PST (sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2) | 2432 |
| PRAD1 (cyclin D1) | 1220 |
| pRb (retinoblastoma 1) | 2374 |
| PRDX4 (peroxiredoxin 4) | 2347 |
| prion (prion protein) | 2347 |
| PRIP (prion protein) | 2347 |
| PRIPR (prostaglandin I2 (prostacyclin) receptor (IP)) | 2363 |
| PRKM7 (mitogen-activated protein kinase 7) | 2261 |
| PRKN (parkinson protein 2, E3 ubiquitin protein ligase (parkin)) | 2325 |
| PRKWNK1 (WNK lysine deficient protein kinase 1) | 2522 |
| PRNP (prion protein) | 2347 |
| PRO2194 (acyl-CoA synthetase long-chain family member 3) | 1043 |
| PROC (protein C (inactivator of coagulation factors Va and VIIIa)) | 2352 |
| PROC1 (protein C (inactivator of coagulation factors Va and VIIIa)) | 2352 |
| PrP (prion protein) | 2347 |
| PrP27-30 (prion protein) | 2347 |
| PrP33-35C (prion protein) | 2347 |
| PrPc (prion protein) | 2347 |
| PRR (nuclear receptor subfamily 1, group I, member 2) | 2309 |
| PRX-4 (peroxiredoxin 4) | 2347 |
| PS1 (presenilin 1) | 2353 |
| PS2 (presenilin 2 (Alzheimer disease 4)) | 2357 |
| PSCP (breast cancer1, early onset) | 1204 |
| PSEN1 (presenilin 1) | 2353 |
| PSEN2 (presenilin 2 (Alzheimer disease 4)) | 2357 |
| PSF1 (transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)) | 2437 |
| PSGD (homeobox B13) | 2150 |
| PSK (WNK lysine deficient protein kinase 1) | 2522 |
| PSK-J3 (cyclin-dependent kinase 4) | 1234 |
| PSORS1 (major histocompatibility complex, class I, C) | 2135 |
| PST (sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1) | 2431 |
| PT (coagulation factor II (thrombin)) | 2047 |
| PTC (ret proto-oncogene) | 2377 |
| Ptg-10 (FK506 binding protein 5) | 2061 |
| PTGER1 (prostaglandin E receptor 1 (subtype EP1), 42kDa) | 2359 |
| PTGER2 (prostaglandin E receptor 2 (subtype EP2), 53kDa) | 2359 |
| PTGER3 (prostaglandin E receptor 3 (subtype EP3)) | 2360 |
| PTGER4 (prostaglandin E receptor 4 (subtype EP4)) | 2361 |
| PTGES (prostaglandin E synthase) | 2362 |
| PTGFR (prostaglandin F receptor (FP)) | 2363 |
| PTGHS (prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)) | 2365 |
| PTGI (prostaglandin I2 (prostacyclin) synthase) | 2364 |
| PTGIR (prostaglandin I2 (prostacyclin) receptor (IP)) | 2363 |
| PTGIS (prostaglandin I2 (prostacyclin) synthase) | 2364 |
| PTGS1 (prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)) | 2365 |
| PTGS2 (prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)) | 2367 |
| PTX1 (C-reactive protein, pentraxin-related) | 1267 |
| PUMB1 (aldehyde dehydrogenase 1 family, member A1) | 1100 |
| PURH (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase) | 1191 |
| PXE (ATP-binding cassette, sub-family C (CFTR/MRP), member 6) | 971 |
| PXE1 (ATP-binding cassette, sub-family C (CFTR/MRP), member 6) | 971 |
| PXR (nuclear receptor subfamily 1, group I, member 2) | 2309 |
| PYY4 (neuropeptide Y) | 2305 |
| Q | |
| QR1 (NAD(P)H dehydrogenase, quinone 1) | 2306 |
| R | |
| R1 (ribonucleotide reductase M1) | 2382 |
| RAD10 (excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)) | 2028 |
| RAD26 (excision repair cross-complementing rodent repair deficiency, complementation group 6) | 2032 |
| RAFB1 (v-raf murine sarcoma viral oncogene homolog B1) | 1203 |
| RALDH (aldehyde dehydrogenase 1 family, member A1) | 1100 |
| RALDH1 (aldehyde dehydrogenase 1 family, member A1) | 1100 |
| RAP3 (apolipoprotein A-V) | 1116 |
| RASK2 (v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) | 2239 |
| RB (retinoblastoma 1) | 2374 |
| RB1 (retinoblastoma 1) | 2374 |
| RCC (X-ray repair complementing defective repair in Chinese hamster cells 1) | 2526 |
| RCCP2 (met proto-oncogene (hepatocyte growth factor receptor) | 2269 |
| RDC4 (5-hydroxytryptamine (serotonin) receptor 1D) | 2161 |
| RDC8 (adenosine A2a receptor) | 1060 |
| REFC (solute carrier family 19 (folate transporter), member 1) | 2404 |
| REN (renin) | 2377 |
| RET (ret proto-oncogene) | 2377 |
| RET51 (ret proto-oncogene) | 2377 |
| RET-ELE1 (ret proto-oncogene) | 2377 |
| RFC1 (solute carrier family 19 (folate transporter), member 1) | 2404 |
| RGP4 (regulator of G-protein signalling 4) | 2380 |
| RGS2 (regulator of G-protein signaling 2, 24kDa) | 2379 |
| RGS4 (regulator of G-protein signalling 4) | 2380 |
| RHEPDGFRA (platelet-derived growth factor receptor, alpha polypeptide) | 2328 |
| RHR (adrenergic, beta-1-, receptor) | 1069 |
| RIC4 (synaptosomal-associated protein, 25kDa) | 2418 |
| RIC-4 (synaptosomal-associated protein, 25kDa) | 2418 |
| RING4 (transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)) | 2437 |
| RIPK7 (leucine-rich repeat kinase 2) | 2253 |
| RIR1 (ribonucleotide reductase M1) | 2382 |
| RN1AH (neurexin 1) | 2318 |
| RNF53C (breast cancer1, early onset) | 1204 |
| ROAT1 (solute carrier family 22 (organic anion transporter), member 6) | 2408 |
| ROCO2 (leucine-rich repeat kinase 2) | 2253 |
| RP (mitochondrially encoded ATP synthase 6) | 2279 |
| RP1-5O6.1 (casein kinase 1, epsilon) | 1272 |
| RP1-23D17.1 (cannabinoid receptor 1 (brain)) | 1257 |
| RP1-130E4.1 (estrogen receptor 1) | 2034 |
| RP1-146H21.1 (NADPH oxidase 1) | 2302 |
| RP1-147M19.1 (dystrobrevin binding protein 1) | 2008 |
| RP1-177P10.1 (complement factor H) | 1244 |
| RP1-201D17__B.1 (monoamine oxidase B) | 2260 |
| RP1-201D17__B.2 (monoamine oxidase A) | 2258 |
| RP1-237C24.1 (solute carrier family 23 (nucleobase transporters), member 2) | 2412 |
| RP1-261G23.1 (vascular endothelial growth factor A) | 2516 |
| RP1-261K5.1 (solute carrier family 22 (organic cation/carnitine transporter), member 16) | 2411 |
| RP3-465G10.1 (ATPase, Cu++ transporting, alpha polypeptide) | 1192 |
| RP3-511B24.2 (topoisomerase (DNA) I) | 2467 |
| RP4-543J19.4 (GNAS complex locus) | 2089 |
| RP4-675E8.4 (lymphocyte-specific protein tyrosine kinase) | 2242 |
| RP5-944H6.1 (prostaglandin F receptor (FP)) | 2363 |
| RP5-1068H6.2 (prion protein) | 2347 |
| RP10 (IMP (inosine monophosphate) dehydrogenase 1) | 2222 |
| RP11-5K23.1 (Fc fragment of IgG, low affinity IIIa, receptor (CD16a)) | 2057 |
| RP11-5K23.6 (Fc fragment of IgG, low affinity IIa, receptor (CD32)) | 2055 |
| RP11-10I9.1 (aminolevulinate dehydratase) | 1099 |
| RP11-67C2.3 (arachidonate 5-lipoxygenase) | 1108 |
| RP11-83J21.1 (c-abl oncogene 1, non-receptor tyrosine kinase) | 1025 |
| RP11-99N20.1 (glutathione S-transferase omega 1) | 2111 |
| RP11-109A6.1 (O-6-methylguanine-DNA methyltransferase) | 2270 |
| RP11-114F7.2 (ATP-binding cassette, sub-family C (CFTR/MRP), member 2) | 944 |
| RP11-127L20.2 (glutathione S-transferase omega 2) | 2113 |
| RP11-130L10.1 (solute carrier family 15 (oligopeptide transporter), member 1) | 2403 |
| RP11-147L20.2 (5-hydroxytryptamine (serotonin) receptor 2A) | 2161 |
| RP11-151D14.2 (aldehyde dehydrogenase 1 family, member A1) | 1100 |
| RP11-153M24.3 (fms-related tyrosine kinase 3) | 2062 |
| RP11-298P3.4 (breast cancer 2, early onset) | 1208 |
| RP11-324O2.5 (acyl-CoA synthetase long-chain family member 5) | 1045 |
| RP11-349N19.3 (glutamate receptor, ionotrophic, AMPA 3) | 2093 |
| RP11-383C12.1 (androgen receptor) | 1183 |
| RP11-419N10.4 (C-reactive protein, pentraxin-related) | 1267 |
| RP11-430G6.1 (regulator of G-protein signalling 4) | 2380 |
| RP11-466J14.4 (cytochrome P450, family 2, subfamily C, polypeptide 18) | 1401 |
| RP11-480N24.7 (solute carrier family 22 (organic anion transporter), member 7) | 2409 |
| RP11-520M5.1 (adducin 1 (alpha)) | 1050 |
| RP11-542K23.6 (prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)) | 2365 |
| RP11-74A12.1 (ATP-binding cassette, sub-family C (CFTR/MRP), member 4) | 965 |
| RP11-753C18.6 (arsenic (+3 oxidation state) methyltransferase) | 1190 |
| RP11-810O3.1 (5-hydroxytryptamine (serotonin) receptor 2C) | 2164 |
| RR1 (ribonucleotide reductase M1) | 2382 |
| RRAS2 (related RAS viral (r-ras) oncogene homolog 2) | 2381 |
| RRM1 (ribonucleotide reductase M1) | 2382 |
| RWS (potassium voltage-gated channel, KQT-like subfamily, member 1) | 2234 |
| RYDR (ryanodine receptor 1 (skeletal)) | 2382 |
| RYR (ryanodine receptor 1 (skeletal)) | 2382 |
| RYR1 (ryanodine receptor 1 (skeletal)) | 2382 |
| S | |
| S5A2 (steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)) | 2425 |
| S12 (5-hydroxytryptamine (serotonin) receptor 1B) | 2159 |
| S863-7 (alpha-2-macroglobulin) | 811 |
| S182 (presenilin 1) | 2353 |
| SANDO (polymerase (DNA directed), gamma) | 2333 |
| SAR (nuclear receptor subfamily 1, group I, member 2) | 2309 |
| SBMA (androgen receptor) | 1183 |
| SCAE (polymerase (DNA directed), gamma) | 2333 |
| SCARB1 (scavenger receptor class B, member 1) | 2384 |
| SCCMS (cholinergic receptor, nicotinic, alpha 1 (muscle)) | 1252 |
| SCFR (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog) | 2237 |
| SCG2 (multiple endocrine neoplasia I) | 2267 |
| SCN1 (sodium channel, voltage-gated, type I, alpha subunit) | 2385 |
| SCN1A (sodium channel, voltage-gated, type I, alpha subunit) | 2385 |
| SCN1B (sodium channel, voltage-gated, type I, beta) | 2386 |
| SCN2A (sodium channel, voltage-gated, type II, alpha subunit) | 2386 |
| SCN2A1 (sodium channel, voltage-gated, type II, alpha subunit) | 2386 |
| SCN2A2 (sodium channel, voltage-gated, type II, alpha subunit) | 2386 |
| SCN3A (sodium channel, voltage-gated, type III, alpha subunit) | 2387 |
| SCN4A (sodium channel, voltage-gated, type IV, alpha subunit) | 2387 |
| SCN5A (sodium channel, voltage-gated, type V, alpha subunit) | 2388 |
| SCN9A (sodium channel, voltage-gated, type IX, alpha subunit) | 2390 |
| SCNEG (sodium channel, nonvoltage-gated 1, gamma) | 2391 |
| SCNN1G (sodium channel, nonvoltage-gated 1, gamma) | 2391 |
| SCOX (acyl-CoA oxidase 1, palmitoyl) | 1041 |
| SCZD9 (regulator of G-protein signalling 4) | 2380 |
| SDR21C1 (carbonyl reductase 1) | 1217 |
| SDR21C2 (carbonyl reductase 3) | 1218 |
| SDR28C1 (hydroxysteroid (17-beta) dehydrogenase 1 ) | 2156 |
| SDY (dystrobrevin binding protein 1) | 2008 |
| SEC9 (synaptosomal-associated protein, 25kDa) | 2418 |
| SelY (deiodinase, iodothyronine, type II) | 1990 |
| SERPINA8 (angiotensinogen (serpin peptidase inhibitor, clade A, member 8)) | 1083 |
| SERT (solute carrier family 6 (neurotransmitter transporter, serotonin), member 4) | 2397 |
| SES1 (carboxylesterase 1 (monocyte/macrophage serine esterase 1)) | 1241 |
| SFD (TIMP metallopeptidase inhibitor 3) | 2450 |
| SG (guanine nucleotide binding protein (G protein), beta polypeptide 3) | 2091 |
| SHEP2 (melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)) | 2266 |
| SIAL2 (sialidase 2 (cytosolic sialidase)) | 2296 |
| SkM1 (sodium channel, voltage-gated, type IV, alpha subunit) | 2387 |
| SKR (tachykinin receptor 2) | 2437 |
| SKR3 (activin A receptor, type II-like 1) | 1046 |
| SKR4 (transforming growth factor, beta receptor 1) | 2448 |
| SKRR (ryanodine receptor 1 (skeletal)) | 2382 |
| SL-1 (matrix metalloproteinase 3 (stromelysin 1, progelatinase)) | 2276 |
| SLC5A5 (solute carrier family 5 (sodium iodide symporter), member 5) | 2392 |
| SLC5A8 (solute carrier family 5 (iodide transporter), member 8) | 2393 |
| SLC6A2 (solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2) | 2394 |
| SLC6A3 (solute carrier family 6 (neurotransmitter transporter, dopamine), member 3) | 2395 |
| SLC6A4 (solute carrier family 6 (neurotransmitter transporter, serotonin), member 4) | 2397 |
| SLC6A5 (solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2) | 2394 |
| SLC10A1 (solute carrier family 10 (sodium/bile acid cotransporter family), member 1) | 2399 |
| SLC10A2 (solute carrier family 10 (sodium/bile acid cotransporter family), member 2) | 2400 |
| SLC11A1 (solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1) | 2401 |
| SLC12A3 (solute carrier family 12 (sodium/chloride transporters), member 3) | 2402 |
| SLC14A2 (solute carrier family 14 (urea transporter), member 2) | 2402 |
| SLC15A1 (solute carrier family 15 (oligopeptide transporter), member 1) | 2403 |
| SLC15A2 (solute carrier family 15 (H+/peptide transporter), member 2) | 2404 |
| SLC19A1 (solute carrier family 19 (folate transporter), member 1) | 2404 |
| SLC21A3 (solute carrier organic anion transporter family, member 1A2) | 2413 |
| SLC21A6 (solute carrier organic anion transporter family, member 1B1) | 2414 |
| SLC21A8 (solute carrier organic anion transporter family, member 1B3) | 2416 |
| SLC21A9 (solute carrier organic anion transporter family, member 2B1) | 2417 |
| SLC21A14 (solute carrier organic anion transporter family, member 1C1) | 2416 |
| SLC22A1 (solute carrier family 22 (organic cation transporter), member 1) | 2406 |
| SLC22A2 (solute carrier family 22 (organic cation transporter), member 2) | 2406 |
| SLC22A4 (solute carrier family 22 (organic cation/ergothioneine transporter), member 4) | 2407 |
| SLC22A6 (solute carrier family 22 (organic anion transporter), member 6) | 2408 |
| SLC22A7 (solute carrier family 22 (organic anion transporter), member 7) | 2409 |
| SLC22A8 (solute carrier family 22 (organic anion transporter), member 8) | 2410 |
| SLC22A16 (solute carrier family 22 (organic cation/carnitine transporter), member 16) | 2411 |
| SLC23A1 (solute carrier family 23 (nucleobase transporters), member 2) | 2412 |
| SLC23A2 (solute carrier family 23 (nucleobase transporters), member 2) | 2412 |
| SLC25A8 (uncoupling protein 2 (mitochondrial, proton carrier)) | 2482 |
| SLC28A1 (solute carrier family 28 (sodium-coupled nucleoside transporter), member 1) | 2412 |
| SLC28A2 (solute carrier family 28 (sodium-coupled nucleoside transporter), member 2) | 2413 |
| SLCO1A2 (solute carrier organic anion transporter family, member 1A2) | 2413 |
| SLCO1B1 (solute carrier organic anion transporter family, member 1B1) | 2414 |
| SLCO1B3 (solute carrier organic anion transporter family, member 1B3) | 2416 |
| SLCO1C1 (solute carrier organic anion transporter family, member 1C1) | 2416 |
| SLCO2B1 (solute carrier organic anion transporter family, member 2B1) | 2417 |
| SMAX1 (androgen receptor) | 1183 |
| SMAX3 (ATPase, Cu++ transporting, alpha polypeptide) | 1192 |
| SMCT (solute carrier family 5 (iodide transporter), member 8) | 2393 |
| SMCT1 (solute carrier family 5 (iodide transporter), member 8) | 2393 |
| SMEI (sodium channel, voltage-gated, type I, alpha subunit) | 2385 |
| SNAP (synaptosomal-associated protein, 25kDa) | 2418 |
| SNAP25 (synaptosomal-associated protein, 25kDa) | 2418 |
| SNAP-25 (synaptosomal-associated protein, 25kDa) | 2418 |
| SNCA (synuclein, alpha (non A4 component of amyloid precursor)) | 2418 |
| SOD2 (superoxide dismutase 2, mitochondrial) | 2420 |
| SOD3 (superoxide dismutase 3, extracellular) | 2424 |
| SP1999 (purinergic receptor P2Y, G-protein coupled, 12) | 2324 |
| SPAT (alanine-glyoxylate aminotransferase) | 1092 |
| SPDA1 (major histocompatibility complex, class I, B) | 2131 |
| SPG5C (spastic paraplegia 7 (pure and complicated autosomal recessive)) | 2425 |
| SPG7 (spastic paraplegia 7 (pure and complicated autosomal recessive)) | 2425 |
| SPGP (ATP-binding cassette, sub-family B (MDR/TAP), member 11) | 928 |
| SPNT1 (solute carrier family 28 (sodium-coupled nucleoside transporter), member 2) | 2413 |
| SPT (alanine-glyoxylate aminotransferase) | 1092 |
| SQT1 (potassium voltage-gated channel, subfamily H (eag-related), member 2) | 2230 |
| SQT2 (potassium voltage-gated channel, KQT-like subfamily, member 1) | 2234 |
| SRB1 (scavenger receptor class B, member 1) | 2384 |
| SR-BI (scavenger receptor class B, member 1) | 2384 |
| SRD5A2 (steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)) | 2425 |
| SRIF-1 (somatostatin receptor 2) | 2427 |
| SS1 (major histocompatibility complex, class II, DR beta 1) | 2141 |
| SS2R (somatostatin receptor 2) | 2427 |
| SS2-R (somatostatin receptor 2) | 2427 |
| SSS1 (sodium channel, voltage-gated, type V, alpha subunit) | 2388 |
| SSTR2 (somatostatin receptor 2) | 2427 |
| SSTR5 (somatostatin receptor 5) | 2427 |
| SS-2-R (somatostatin receptor 2) | 2427 |
| SS-5-R (somatostatin receptor 5) | 2427 |
| ST1A1 (sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1) | 2431 |
| ST1A2 (sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2) | 2432 |
| ST1A3 (sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1) | 2431 |
| ST1A5 (sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3) | 2433 |
| ST1C1 (sulfotransferase family, cytosolic, 1C, member 2) | 2435 |
| ST1C2 (sulfotransferase family, cytosolic, 1C, member 2) | 2435 |
| STAT3 (signal transducer and activator of transcription 3 (acute-phase response factor)) | 2428 |
| STE (sulfotransferase family 1E, estrogen-preferring, member 1) | 2435 |
| STK1 (fms-related tyrosine kinase 3) | 2062 |
| STM (sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3) | 2433 |
| STM2 (presenilin 2 (Alzheimer disease 4)) | 2357 |
| STMY (matrix metalloproteinase 3 (stromelysin 1, progelatinase)) | 2276 |
| STMY1 (matrix metalloproteinase 3 (stromelysin 1, progelatinase)) | 2276 |
| STP (sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1) | 2431 |
| STP1 (sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1) | 2431 |
| STP2 (sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2) | 2432 |
| STR1 (matrix metalloproteinase 3 (stromelysin 1, progelatinase)) | 2276 |
| SULT1A1 (sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1) | 2431 |
| SULT1A2 (sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2) | 2432 |
| SULT1A3 (sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3) | 2433 |
| SULT1A4 (sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3) | 2433 |
| SULT1C1 (sulfotransferase family, cytosolic, 1C, member 2) | 2435 |
| SULT1C2 (sulfotransferase family, cytosolic, 1C, member 2) | 2435 |
| SULT1E1 (sulfotransferase family 1E, estrogen-preferring, member 1) | 2435 |
| SUR (ATP-binding cassette, sub-family C (CFTR/MRP), member 8) | 979 |
| SUR1 (ATP-binding cassette, sub-family C (CFTR/MRP), member 8) | 979 |
| SVCT2 (solute carrier family 23 (nucleobase transporters), member 2) | 2412 |
| sWSS2608 (IMP (inosine monophosphate) dehydrogenase 1) | 2222 |
| SXR (nuclear receptor subfamily 1, group I, member 2) | 2309 |
| T | |
| TA2R (thromboxane A2 receptor) | 2439 |
| TAC2R (tachykinin receptor 2) | 2437 |
| TACR2 (tachykinin receptor 2) | 2437 |
| T-ALK (bone morphogenetic protein receptor, type II (serine/threonine kinase)) | 1202 |
| Tangier (ATP-binding cassette, sub-family A (ABC1), member 1) | 812 |
| TAP1 (transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)) | 2437 |
| TAP1*0102N (transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)) | 2437 |
| TAP1N (transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)) | 2437 |
| TAU (microtubule-associated protein tau) | 2261 |
| TBE-1 (matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)) | 2274 |
| TBE1 (matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)) | 2274 |
| TBET (T-box 21) | 2438 |
| T-bet (T-box 21) | 2438 |
| T-BET (T-box 21) | 2438 |
| TBLYM (T-box 21) | 2438 |
| TBP1 (tumor necrosis factor receptor superfamily, member 1A) | 2464 |
| TBPII (tumor necrosis factor receptor subfamily, member 1B) | 2465 |
| TBX21 (T-box 21) | 2438 |
| TBXA2R (thromboxane A2 receptor) | 2439 |
| TBXAS1 (thromboxane A synthase 1 (platelet)) | 2440 |
| TC21 (related RAS viral (r-ras) oncogene homolog 2) | 2381 |
| tcag7.78 (cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)) | 1245 |
| TCF (hepatocyte nuclear factor 4, alpha) | 2147 |
| TCF14 (hepatocyte nuclear factor 4, alpha) | 2147 |
| TCGF (interleukin 2) | 2198 |
| TCS1 (telomerase reverse transcriptase) | 2440 |
| TDH1 (solute carrier family 5 (sodium iodide symporter), member 5) | 2392 |
| TERT (telomerase reverse transcriptase) | 2440 |
| TFM (androgen receptor) | 1183 |
| TGD (ATP-binding cassette, sub-family A (ABC1), member 1) | 812 |
| TGFB (transforming growth factor, beta 1) | 2442 |
| TGFB1 (transforming growth factor, beta 1) | 2442 |
| TGFbeta (transforming growth factor, beta 1) | 2442 |
| TGFBR1 (transforming growth factor, beta receptor 1) | 2448 |
| TGFR-1 (transforming growth factor, beta receptor 1) | 2448 |
| TGH (carboxylesterase 1 (monocyte/macrophage serine esterase 1)) | 1241 |
| TGIF (interleukin 10) | 2213 |
| THAS (thromboxane A synthase 1 (platelet)) | 2440 |
| THBD (thrombomodulin) | 2449 |
| THRM (thrombomodulin) | 2449 |
| Thrombin (coagulation factor II (thrombin)) | 2047 |
| TIMP3 (TIMP metallopeptidase inhibitor 3) | 2450 |
| TKR1 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)) | 2023 |
| TLH6 (alanine-glyoxylate aminotransferase) | 1092 |
| TL-PST (sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3) | 2433 |
| TLR4 (toll-like receptor 4) | 2451 |
| TM (thrombomodulin) | 2449 |
| TMAU (flavin containing monooxygenase 3) | 2067 |
| TMBIM3 (glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding)) | 2097 |
| TMS (thymidylate synthetase) | 2479 |
| TNDM2 (ATP-binding cassette, sub-family C (CFTR/MRP), member 8) | 979 |
| TNDM3 (potassium inwardly-rectifying channel, subfamily J, member 11) | 2232 |
| TNF (tumor necrosis factor (TNF superfamily, member 2) | 2453 |
| TNFA (tumor necrosis factor (TNF superfamily, member 2) | 2453 |
| TNF-alpha (tumor necrosis factor (TNF superfamily, member 2) | 2453 |
| TNFAR (tumor necrosis factor receptor superfamily, member 1A) | 2464 |
| TNFB (lymphotoxin alpha (TNF superfamily, member 1)) | 2254 |
| TNFBR (tumor necrosis factor receptor subfamily, member 1B) | 2465 |
| TNFR1B (tumor necrosis factor receptor subfamily, member 1B) | 2465 |
| TNF-R (tumor necrosis factor receptor superfamily, member 1A) | 2464 |
| TNFR1 (tumor necrosis factor receptor superfamily, member 1A) | 2464 |
| TNFR2 (tumor necrosis factor receptor subfamily, member 1B) | 2465 |
| TNFR55 (tumor necrosis factor receptor superfamily, member 1A) | 2464 |
| TNF-R55 (tumor necrosis factor receptor superfamily, member 1A) | 2464 |
| TNFR60 (tumor necrosis factor receptor superfamily, member 1A) | 2464 |
| TNF-R75 (tumor necrosis factor receptor subfamily, member 1B) | 2465 |
| TNFR80 (tumor necrosis factor receptor subfamily, member 1B) | 2465 |
| TNF-R-I (tumor necrosis factor receptor superfamily, member 1A) | 2464 |
| TNF-R-II (tumor necrosis factor receptor subfamily, member 1B) | 2465 |
| TNFRSF1A (tumor necrosis factor receptor superfamily, member 1A) | 2464 |
| TNFRSF1B (tumor necrosis factor receptor subfamily, member 1B) | 2465 |
| TNFSF1 (lymphotoxin alpha (TNF superfamily, member 1)) | 2254 |
| TNFSF2 (tumor necrosis factor (TNF superfamily, member 2) | 2453 |
| TNR-CFTR (cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)) | 1245 |
| TOLL (toll-like receptor 4) | 2451 |
| TOP1 (topoisomerase (DNA) I) | 2467 |
| TOPI (topoisomerase (DNA) I) | 2467 |
| TP2 (telomerase reverse transcriptase) | 2440 |
| TP16 (cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4)) | 1238 |
| TP53 (tumor protein p53) | 2468 |
| TP53I12 (prostaglandin E synthase) | 2362 |
| TP103 (dipeptidyl-peptidase 4) | 1992 |
| T-PET (T-box 21) | 2438 |
| TPH1 (tryptophan hydroxylase 1) | 2474 |
| TPH2 (tryptophan hydroxylase 2) | 2475 |
| TPK1 (glycogen synthase kinase 3 beta) | 2099 |
| TPMT (thiopurine S-methyltransferase) | 2477 |
| TPRH (tryptophan hydroxylase 1) | 2474 |
| TRIP14 (2′-5′-oligoadenylate synthetase-like) | 2321 |
| TRKB (neurotrophic tyrosine kinase, receptor, type 2) | 2318 |
| trnK (mitochondrially encoded tRNA lysine) | 2284 |
| TRNL1 (mitochondrially encoded tRNA leucine 1 (UUA/G)) | 2285 |
| TRP53 (tumor protein p53) | 2468 |
| TRPH (tryptophan hydroxylase 1) | 2474 |
| TRPV1 (transient receptor potential cation channel, subfamily V, member 1) | 2478 |
| TRT (telomerase reverse transcriptase) | 2440 |
| TS (thromboxane A synthase 1 (platelet)) | 2440 |
| TS (thymidylate synthetase) | 2479 |
| TSC (solute carrier family 12 (sodium/chloride transporters), member 3) | 2402 |
| TSPST2 (sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2) | 2432 |
| TSR-I (activin A receptor, type II-like 1) | 1046 |
| TTD (excision repair cross-complementing rodent repair deficiency, complementation group 2) | 2029 |
| TXA2-R (thromboxane A2 receptor) | 2439 |
| TXAS (thromboxane A synthase 1 (platelet)) | 2440 |
| TXDI2 (deiodinase, iodothyronine, type II) | 1990 |
| TXS (thromboxane A synthase 1 (platelet)) | 2440 |
| TYMS (thymidylate synthetase) | 2479 |
| U | |
| U21B31 (cyclin D1) | 1220 |
| U62968.1 (solute carrier family 28 (sodium-coupled nucleoside transporter), member 1) | 2412 |
| U77086.1 (solute carrier family 22 (organic cation transporter), member 1) | 2406 |
| UCP2 (uncoupling protein 2 (mitochondrial, proton carrier)) | 2482 |
| UCPH (uncoupling protein 2 (mitochondrial, proton carrier)) | 2482 |
| UDB7 (UDP glucuronosyltransferase 2 family, polypeptide B7) | 2506 |
| UDPGT (UDP glucuronosyltransferase 1 family, polypeptide A1) | 2483 |
| UDPGT (UDP glucuronosyltransferase 1 family, polypeptide A10) | 2502 |
| UDPGT (UDP glucuronosyltransferase 1 family, polypeptide A3) | 2490 |
| UDPGT (UDP glucuronosyltransferase 1 family, polypeptide A4) | 2493 |
| UDPGT (UDP glucuronosyltransferase 1 family, polypeptide A6) | 2495 |
| UDPGT (UDP glucuronosyltransferase 1 family, polypeptide A7) | 2497 |
| UDPGT (UDP glucuronosyltransferase 1 family, polypeptide A9) | 2500 |
| UDPGT 1-1 (UDP glucuronosyltransferase 1 family, polypeptide A1) | 2483 |
| UDPGT 1-3 (UDP glucuronosyltransferase 1 family, polypeptide A3) | 2490 |
| UDPGT 1-4 (UDP glucuronosyltransferase 1 family, polypeptide A4) | 2493 |
| UDPGT 1-6 (UDP glucuronosyltransferase 1 family, polypeptide A6) | 2495 |
| UDPGT 1-7 (UDP glucuronosyltransferase 1 family, polypeptide A7) | 2497 |
| UDPGT 1-9 (UDP glucuronosyltransferase 1 family, polypeptide A9) | 2500 |
| UDPGT2B7 (UDP glucuronosyltransferase 2 family, polypeptide B7) | 2506 |
| UDPGT2B8 (UDP glucuronosyltransferase 2 family, polypeptide B15) | 2509 |
| UDPGT2B9 (UDP glucuronosyltransferase 2 family, polypeptide B7) | 2506 |
| UDPGT2B15 (UDP glucuronosyltransferase 2 family, polypeptide B15) | 2509 |
| UDPGTH2 (UDP glucuronosyltransferase 2 family, polypeptide B7) | 2506 |
| UDPGTH3 (UDP glucuronosyltransferase 2 family, polypeptide B15) | 2509 |
| UDPGTh-3 (UDP glucuronosyltransferase 2 family, polypeptide B15) | 2509 |
| UGT1 (UDP glucuronosyltransferase 1 family, polypeptide A1) | 2483 |
| UGT1 (UDP glucuronosyltransferase 1 family, polypeptide A3) | 2490 |
| UGT1 (UDP glucuronosyltransferase 1 family, polypeptide A4) | 2493 |
| UGT1*1 (UDP glucuronosyltransferase 1 family, polypeptide A1) | 2483 |
| UGT1*7 (UDP glucuronosyltransferase 1 family, polypeptide A7) | 2497 |
| UGT1.3 (UDP glucuronosyltransferase 1 family, polypeptide A3) | 2490 |
| UGT1.10 (UDP glucuronosyltransferase 1 family, polypeptide A10) | 2502 |
| UGT1-03 (UDP glucuronosyltransferase 1 family, polypeptide A3) | 2490 |
| UGT1-04 (UDP glucuronosyltransferase 1 family, polypeptide A4) | 2493 |
| UGT1-06 (UDP glucuronosyltransferase 1 family, polypeptide A6) | 2495 |
| UGT1-09 (UDP glucuronosyltransferase 1 family, polypeptide A9) | 2500 |
| UGT1-10 (UDP glucuronosyltransferase 1 family, polypeptide A10) | 2502 |
| UGT1A (UDP glucuronosyltransferase 1 family, polypeptide A1) | 2483 |
| UGT1A1 (UDP glucuronosyltransferase 1 family, polypeptide A1) | 2483 |
| UGT1A3 (UDP glucuronosyltransferase 1 family, polypeptide A3) | 2490 |
| UGT1A4 (UDP glucuronosyltransferase 1 family, polypeptide A4) | 2493 |
| UGT1A5 (UDP glucuronosyltransferase 1 family, polypeptide A1) | 2483 |
| UGT1A6 (UDP glucuronosyltransferase 1 family, polypeptide A6) | 2495 |
| UGT1A6S (UDP glucuronosyltransferase 1 family, polypeptide A6) | 2495 |
| UGT1A7 (UDP glucuronosyltransferase 1 family, polypeptide A7) | 2497 |
| UGT1A9 (UDP glucuronosyltransferase 1 family, polypeptide A9) | 2500 |
| UGT1A10 (UDP glucuronosyltransferase 1 family, polypeptide A10) | 2502 |
| UGT1AI (UDP glucuronosyltransferase 1 family, polypeptide A9) | 2500 |
| UGT1C (UDP glucuronosyltransferase 1 family, polypeptide A3) | 2490 |
| UGT1D (UDP glucuronosyltransferase 1 family, polypeptide A4) | 2493 |
| UGT1F (UDP glucuronosyltransferase 1 family, polypeptide A6) | 2495 |
| UGT1G (UDP glucuronosyltransferase 1 family, polypeptide A7) | 2497 |
| UGT1J (UDP glucuronosyltransferase 1 family, polypeptide A10) | 2502 |
| UGT-1J (UDP glucuronosyltransferase 1 family, polypeptide A10) | 2502 |
| UGT2B7 (UDP glucuronosyltransferase 2 family, polypeptide B7) | 2506 |
| UGT2B8 (UDP glucuronosyltransferase 2 family, polypeptide B15) | 2509 |
| UGT2B9 (UDP glucuronosyltransferase 2 family, polypeptide B7) | 2506 |
| UGT2B15 (UDP glucuronosyltransferase 2 family, polypeptide B15) | 2509 |
| UNQ411/PRO773 (apolipoprotein A-V) | 1116 |
| UNQ868/PRO1885 (angiotensin I converting enzyme (peptidyl-dipeptidase A) 2) | 1034 |
| URA1 (dihydroorotate dehydrogenase) | 1989 |
| URG7 (ATP-binding cassette, sub-family C (CFTR/MRP), member 6) | 971 |
| USF2 (upstream transcription factor 2, c-fos interacting) | 2510 |
| USP5 (ubiquitin specific peptidase 5 (isopeptidase T)) | 2511 |
| UT2 (solute carrier family 14 (urea transporter), member 2) | 2402 |
| UTA (solute carrier family 14 (urea transporter), member 2) | 2402 |
| UT-A2 (solute carrier family 14 (urea transporter), member 2) | 2402 |
| UTR (solute carrier family 14 (urea transporter), member 2) | 2402 |
| UV20 (excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)) | 2028 |
| V | |
| v-abl (c-abl oncogene 1, non-receptor tyrosine kinase) | 1025 |
| VAP1 (vascular cell adhesion molecule 1) | 2512 |
| VCAM1 (vascular cell adhesion molecule 1) | 2512 |
| VDR (vitamin D (1,25- dihydroxyvitamin D3) receptor) | 2513 |
| VEGF (vascular endothelial growth factor A) | 2516 |
| VEGFA (vascular endothelial growth factor A) | 2516 |
| VEGF-A (vascular endothelial growth factor A) | 2516 |
| VEGFR (kinase insert domain receptor (a type III receptor tyrosine kinase)) | 2236 |
| VEGFR2 (kinase insert domain receptor (a type III receptor tyrosine kinase)) | 2236 |
| VF1 (sodium channel, voltage-gated, type V, alpha subunit) | 2388 |
| VGF (VGF nerve growth factor inducible) | 2520 |
| VKCFD1 (gamma-glutamyl carboxylase) | 2082 |
| VKCFD2 (vitamin K epoxide reductase complex, subunit 1) | 2520 |
| VKOR (vitamin K epoxide reductase complex, subunit 1) | 2520 |
| VKORC1 (vitamin K epoxide reductase complex, subunit 1) | 2520 |
| VLA-2 (integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)) | 2224 |
| VLAA2 (integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)) | 2224 |
| VPF (vascular endothelial growth factor A) | 2516 |
| VR1 (transient receptor potential cation channel, subfamily V, member 1) | 2478 |
| W | |
| WHITE1 (ATP-binding cassette, sub-family G (WHITE), member 1) | 985 |
| WNK1 (WNK lysine deficient protein kinase 1) | 2522 |
| WNT5B (Wingless-type MMTV integration site family, member 5B) | 2523 |
| WRS (potassium voltage-gated channel, KQT-like subfamily, member 1) | 2234 |
| X | |
| X98333.1 (solute carrier family 22 (organic cation transporter), member 2) | 2406 |
| XDH (xanthyne deydrogenase) | 2524 |
| XO (xanthyne deydrogenase) | 2524 |
| XOR (xanthyne deydrogenase) | 2524 |
| XP1 (xeroderma pigmentosum, complementation group A) | 2525 |
| XPA (xeroderma pigmentosum, complementation group A) | 2525 |
| XPAC (xeroderma pigmentosum, complementation group A) | 2525 |
| XPD (excision repair cross-complementing rodent repair deficiency, complementation group 2) | 2029 |
| XRCC1 (X-ray repair complementing defective repair in Chinese hamster cells 1) | 2526 |
| XXbac-BCX101P6.2 (major histocompatibility complex, class I, C) | 2135 |
| XXbac-BPG161M6.1 (major histocompatibility complex, class II, DR beta 1) | 2141 |
| Y | |
| YSPL2 (solute carrier family 23 (nucleobase transporters), member 2) | 2412 |
| YT (acetylcholinesterase (Yt blood group) | 1036 |
| YT16 (lymphocyte-specific protein tyrosine kinase) | 2242 |
| Z | |
| ZA20D3 (zinc finger, AN1-type, domain 6) | 2529 |
| ZFAND5B (zinc finger, AN1-type, domain 6) | 2529 |
| ZFAND6 (zinc finger, AN1-type, domain 6) | 2529 |
| ZNF32 (adrenergic, alpha-2A-, receptor) | 1064 |
